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ABSTRACT
The effects of facilitatory drugs (neostigmine, edrophonium, amben~:

,

'

onium and methoxyambenonium) at the skeletal neuromuscular junction
have been studied using intracellular microelectrodes in the isolated
tenuissimus muscle of the cat.

These drugs produced small changes in

miniature end-plate potential (m. e. p. p.) frequency.

The m. e. p. p. s were

prolonged by neostigmine, ambenonium and methoxyambenonium, but not
by edrophonium.

High concentrations of neostigmine and edrophonium

depressed the m. e. p. p. amplitude concurrent with a decrease in the

resting mc.i..n.b!'ane potential.

High c-0nccntr:::1.tions cf ::>cmb•=""'0l"li 11 rn

~ni4

methoxyambenonium depressed the m. e. p. p. amplitude with no change in
the resting membrane potential.

The amplitude of (+)-tubocurarine end-plate potentials (e. p. p. s) was
increased without change in time-course by all four drugs at a
tion which had no effect on m. e. p. p. s.

conc~ntra:

The half-decay of (+)-tubocurar.i.ne

e. p. p. s was prolonged at the same concentration which prolonged the
m. e. p. p. s.

On the other hand the facilitatory drugs produced nearly

equivalent changes in (+)-tubocurarine e. p. p. s and iontophoretic acetylcholine-potentials.

..

The drugs did not increase the quanta! release in

ma

aa

-
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deficient calcium and high magnesium ion concentrations.
ium e. p. p. s were not affected by the facilitatory drugs.

BenzoquinonThese results

are discussed in conjunction with the current theories of neuromuscular
pharmacology.
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INTRODUCTION

I
\

\

~

--------~-------------------~--------------------':"""""'----.
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~~tomy

of the neuromuscular junction

Motor nerve axons originate in the ventral root of the spinal. cord and
extend to the periphery where they make synaptic contact with skeletal
muscle fibers (Sherrington, 1925 and Tiegs, 1932).

The motor nerve

axon is a large diameter neuron surrounded by layers of myelin, produced
by an associated Schwann ·cell {Geren, 1954 and Robertson, 1955).

Because

a single motor nerve branches in the nerve trunk (Adrian, 1925) and near
the muscle fiber, it can innervate between 100 and 200 muscle fibers
(Fulton, 1926 and Clark, 1931).

The nerve, together with its muscle

is called a 'motor unit' (Sherrington, 1925).

fibers~.

The muscle fibers of a motor

unit are arranged in a longitudinal or chain-like manner (Adrian, 1925 and
Cooper, 1929).

Until the development of electronmicroscopy, there was much debate
concerning the anatomy of the neuromuscular junction.
its myelin sheath at the terminal.

The nerve loses

The nerve terminal, which has a

diameter of 2 to 3 microns lies in a synaptic trough on the surface of the
!
\

muscle fiber (Anderson-Cede.rgren, 1959 and DeHarven and Coers, 1959).
A Schwann cell always encloses the surface of the nerve terminal away
from the synapse (Birks, :fluxley and Katz, 1960).

The axoplasm does not

make cont;l.ct with the sarcoplasm (Reger, 1954) but is separated by a
five-layered membrane, the synaptolemma.

The synaptolemma is com-

10
posed of neurilemma and sarcolemma which combine in the area of the
neuromuscular junction (Robertson, 1954; Couteaux, 1958 and Reger, 1958).
The nerve terminal and muscle end-plate (e. p.) are separated by a primary
synaptic cleft which is 200 Angstrom units wide {Palay, 1958).

In the

region of the nerve terminal the muscle membrane is thrown into a series
of junctional folds- -secondary synaptic clefts (Pa.lade and Palay, 1954;
Reger, 1954 and -Robertson, 1954).

They are approximately one micron

long and one-tenth micron wide, being narrower toward the axonal surface
(Robertson, 1956).

The junctional folds probably are the "subneural

apparatus" which is so prominent "in Couteaux's (1955) light microscope
::=ections.

The axoplasm which doe$ not dip into the junctional folds is distinguished by the presence of mitochondria {Robertson, 1956).

Another distin-

guishing feature of the axoplasm is the occurrence of "synaptic vesicles"
(300 to 500 Angstrom units in diameter) which are concentrated near dense
presynaptic membra11e areas directly opposite a junctional fold (Birks,
Huxley and Katz, 1960 and Hubbard and Kwanbunbumpen, 1968).

Birks (1966) made an unusual observation.

By using acrolein as a

fixing agent, rather than osmium tetraoxjde, a tubular system appeared
in tt;ie nerve terminal a.xoplasm.

Thus vesicles may be a fixation artifact.

11
~~_!:_ology

of the neuromuscular junction

In a quiescent nerve-muscle preparation, small depolarizations of the
membrane occur at the end-plate region of the muscle fiber.

These

miniature end-plate potentials (m. e. p. p. s)-initially called "end-plate
noise" (Fatt and Katz, 1950)-have been recorded in several species,
including frog (Fatt and Katz, 1950), rat (Liley, 1956a). guinea pig (Brooks,
1956b), cat (Boyd and Martin, 1956a) and human (Elmqvist, Johns and
Thesleff, 1960).

Each rh. e. p. p. is due to the spontaneous release of a

single quantum, which contains many molecules of transmitter (Fatt and
Katz, 1952; Liley, 1956a and Boyd and Martin, 1956a}.
r tlta>:>c:d froiu the nerve tern1inal (Fati. and Katz, 18 52),

These quanta are
c..1-::hvi..i.~1:..

they

i110.y

originate from other structures (Birks, Katz and Miledi, 1960).
Upon activation of the motor nerve an action potential invades the motor
nerve terminal, where it initiates the release of transmitter (Hubbard and
Schmidt, 1962 and Katz and Miledi, 1965c).

In the unmyelinated terminal

the action potential has a slow conduction velocity and long after-potentials.
i

These characteristics are typical of an unmyelinated C-fiber (\Verner, 1960a; ·
Hubbard and Schmidt, 1961; Blaber and Bowman, 1963b; Katz and Miledi, 1965
When transmitter release is measured in the presence of deficient
calicum ions or excess magnesium ions, the end-plate depolarization
(end-plate potential- -e. p. p. ) becomes quite small.

If the calcium ion con-

centration is sufficiently low, the e. p. p. a.m·plitude fluctuates considerably
with many of the e. p. p. s having exactly the same amplitude and time
·course as m. e. p. p. s.

The smallest e. p. p. s which occur are essentially

m. e. p. p. s and the larger e. p. p. s are multiple m. e. p. p. s (Fatt and Katz,
1952}.

The e. p. p. amplitude in deficient calcium follows a Poisson

distribution indicating an independent release of quanta from the activated
terminal (del Castillo and Katz, 1954b; Martin, 1955; Boyd and Martin;
1956b; and Liley, 1956b).

On the basis of these results Liley (1956c) and

Katz (1962) concluded that a nerve stimulus merely increases the rate
of spontaneous release of transmitter.

On first analysis there appeared to be a correlation between the
amplitude of the nerve terminal depolarization and the release of transmitt er.

This relationship was arrived at by correlating the calculated

depolarization induced by various extracellular potassium ion concentrations with the changes of m. e. p. p. frequency induced by the corresponding
'

I._

potassium ion concentration.

Liley (1956c) stated that a 15 millivolt (mV)

depolarization produces a ten-fold increase in m. e. p. p. frequency.
According to his hypothesis, the nerve terminal action potential increases
the release of transmitter by increasing the m. e. p. p. frequency in a
logarithmic fashion.
release.

No other steps were considered necessary for

On the basis of Liley' s results it was possible to account for
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all the quanta released by an action potential.

Due to the logarithmic na.:. ·

ture of the release, most of the release would occur at the peak of the
action potential, when the m. e. p. p. frequency would be extremely high
(Eccles and Liley.. 1959).

This theory also accounted for the observation

that depolarization of the nerve terminal decreased the amplitude of the
e. p. p. (Hubbard and w·illis, 1962b and 1968 and Vladimirova, 1964) and
hyperpolarization of the terminal increased the amplitude of the e. p. p.
(del Castillo and Katz, 1954b: Hubbard and Willis, 1962a and 1962c and
Vladimirova. 1964). On the basis of Lloyd's results {1950) in the spinal
cord, Eccles and Liley (1959) concluded that depolarization decreased the
amplitude of the terminal spike and thereby, decreased transmitter release;
while hy-perpolarization increased the amplitude of the terminal spike and
increased transmHter release.

Although this simple theory was quite attractive, data began to
accumulate indicating that transmitter release involves much more than
just depolarization of the nerve terminal (Hubbard and Schmidt, 1963;
Katz and MilecU, l965d, 1965e and 1967a and Hubbard, Jones and Landau,
1967).

It has been shown that calcium ions are eosential for neurornuscular

transmission (F:-.

~,

1936; Cowan, 1940; Kuffler, 1944; del Castillo aud

Stark, 1952; Fatt and Katz, 1952; del Castillo and Katz, 1954b; Boyd and
Martin, 1956b and Liley, 1956c) and for spontaneous release of transmitter

14
(Boyd and Martin, 19 56a; Elmqvist and Feldman, 19 65a; Hubbard, 19 61 and
Hubbard,Jones and Landau, 1968a).

Lowering the calcium ion concentration

decreases transmitter release with no effect on the nerve terminal action
potential (Katz and Miledi, 1965d, 1965e and 1967a).
had to be modified to include a calcium step.

Thus Liley's theory

The exact mechanism by

which calcium ions affect release of transmitter is not known.

Del

Castillo and Katz (1954a and 1954c) hypothesized that calcium ,acts with an
external component of the nerve terminal (X).

The complex (CaX) moves

intraterminally during the terminal action potential and causes the release
of a quantum of transmitter (Gage, 1967; Hubbard, Jones and Landau, 1968a;
RahamimofI, 1968 and Katz and Miledi, 1968).

Raharn.imuff (1963) and

D0dg~

and Rahamimoff (1967) have further hypothesized that four calcium ions are
necessary to release one quantum of transmitter.

This action of calcium is

quite rapid and can be shown to occur even during the falling phase of the
terminal action potential (Katz and Miledi, 1967a and 1967c).

Calcium can

be replaced in this 9.CtTun by strontium or barium ions (Elmqvist and
Feldman, 1965a and Miledi, 1966).

All the actions of calcium ions which have been previously described at
the neuromuscular junction are antagonized by magnesium ions.

The mag-

nesium ions decrease release of transmitter by competitively inhibiting
the action of calcium ions (Del Castillo and Engback, 1954; Del Castillo and

15
Katz, 1954a; Huiier and Kostial, 1954; Liley, 1956c; Jenkinson, 1957;
Hubbard, 1961; Hubbard and Willis,1962c and 1968; Hubbard and Schmidt,
1963 and Hubbard,, Jones and Landau, 1968a).

Magnesium ions may augment

release, except their activity in this regard is much less than the activity
of calcium ions ' (Hubbard, Jones and Landau, 1968a).

Some workers also involve sodium ions, directly, in the release of
transmitter. rather than through any effects on the sodium conductance of
the terminal action potential.

Changing the sodium ion concentration has

no effect on release in a normal ionic solution {Del Castillo and Katz, 1955b
and Co1omo and Rahamimoff, 1968).

When the muscle is immersed in

tetrodotoxin, which blocks sodium conductance changes in nerve or muscle,
release is normal (Elmqvist and Feldman, 1965c and Katz and Milcdi, J967h)
But in a deficient calcium ion concentration, .a decrease in the sodium
ion concentration '\Vill increase m. e. p. p. frequency, augment the e. p. p.
and increase the quantal content of the e. p. p. (Gage and Quastel, 1965b and
1966; Kelly, 1965; Rahamimoff and Colomo, 1967 and Colomo and Rahamimoff1 1968).

It has been hypothesized that sodium ions compete extrater-

minally with the calcium ions for the receptor (X).

Digoxin and ouabain inhibit the sodium-potassium pump by inhibiting
ATPase.

They cause an inc~e::e :ease =nsmitter whlch must

J.

~-------------------------------------------------------------------------~
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be due to a build up of sodium ions intraterminally (Birks, 1962 and 1963
and Elmqvist s.nd Feldman,1965b).

Thus it has been further hypothesized

that sodium ions compete with calcium ions intraterminally,

as well as

extraterrninally (Birks. and Cohen, 1965, 1968a and 1968b).

Gage and Quastel (1965a) and Parsons, Hofmann and Feigen (1965) have
involved potassium ions in the release of transmitter; although it is quite
difficult to distinguish between indirect effects on the nerve terminal
membrane potential and direct effects on transmitter release.

Chloride ions are not involved in the release of transmitter (Elm.qvist
and Feldman. 1966).

Hypoxia, stretch, increased osmotic pressure and increased
temperature all increase m. e. p. p. frequency and all, except hypoxia.,
·increase the release of transmitter.

Hypoxia decreases release, and prob-

_ably does so by blocking the sodium-potassium pump, thereby depolarizing
the terminal membrane (Hubbard and Loyning, 1966).

Stretch, increased

osmotic pressure and increased temperature act by different mechanisms
to increase release (Fatt and Katz, 1952; Boyd and Martin, 1956a and
1956b; Furshspan, 1956; Hutter and Trautwein, 1956; Liley, 1956a;
Takeuchi, 1958b and Hubbard, Jones and Landau, 1968b).
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Since the ·work of Dale and his co-workers, it is generally accepted th2.t
acetylcholine (ACh) is the transmitter at the neuromuscular junction.
ACh has been isolated from a neuromuscular preparation following
indirect stirnulationJDale, Feldberg and Vogt,

19~i6)

and this ACh arises

from the nerve (Straughan, 1960 and Krnjevic and Mitchell, 1961).
Inj ected P.Ch mimics the effects of indirect stimulation (Brown, Dale
and Feldberg, 1936 and Brown, 1937).

Also, the synthesizing and

degradating enzymes for A Ch are present (Marneymd Nachmansohn, 19311
and Nachmansohn and Machado, 1943}.

ACh is synthesized from choline and acetyl co-enzyme A in the
pre.scEc.e of the enzyine, choline acetyl transfercise-ChAc (Nachmansohn
and Machado; 1913 and Korkes, Del Campillo, Korey, Stern, Nachmansolm
and Ochoa, 1952).

The site of synthesis is not established.

rt has been

suggested that synthesis may take place in the terminal axoplasm
(V./hitt8ker, Michaelson and Kirkland, 1964 and Michaelson, 1967),

mitochondria (Bodian, 1942 and Hebb and Smallnian, 1956) or synaptic
vesicles (Hebb and Whittak2r,

19~18;

Vvhittakcr, 1959 and DeRobertis,

Arnaiz, S2.lganiccff, Iraldi and Zieher, 1963).

The ACh is stored in a

bound form (Elliot and Henderson, 1951 and Brodkin and Elliot, 1953).
Many workers feel that the vesicles in the electronrnicrograph represent
the 'bour1d for'm of ACh (DeRobertis and Bennett, 1955; Del Castillo and

•
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Katz, 1955b; Macintosh, 1959 and Hubbard and Kwanbunbumpen, · 1968).

The transmitter whie:h is present in the nerve terminal can

be

divided into two functionally, distinct stores- -"the available store" which
is readily releaseable, and the "unavailable store" which is not readily
releaseable.

An indirect stimulus depletes the available store.

This

store is rapidly refilled {Gage and. Hubbard, 1965) from the uriavailable
store.

The unavailable store is comparatively, slowly filled; as it depends

on synthesis for its transmitter (Perry, 1953; Birks and Macintosh, 1957
and 1961 and Thies, 1960).

The available store may be represented by the

vesicles which are located near the region of the presynaptic membrane,
while the unavailable store may be the vesicles which are further from the
membrane (Hubbard and Kwanbunbumpen, 1968).

Elmqvist and Quastel

(1965} and Elmqvist (1965) estimate the total releaseable store to be
around 200, 000 quanta.

The mechanism whereby the vesicle extrudes its contents from the
nerve terminal is unknown, but probably involves contact of the vesicle
with the presynaptic membrane.

In this way the vesicle ejects the

transmitter directly into the synaptic gap (Katz, 1962; Bass and
1966 and Hubbard, Jones and Landau, 1967).

Moor~,

Hubbard and Kwanbunbumpen

(1968) were able to observe a few vesicles which were fused with the

:

.
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terminal membrane.

Once the transmitter is released, it rapidly diffuses

throughout the synaptic gap (Eccles and Jaeger, 1958) and comes into
contact with at least two types of receptors -- acetylcholinesterase and
the junctional receptor.

The neuromuscular junction contains a high

concentration of the degrading enzyme for ACh, acetylcholinesterase
(Feng and Ting, 1938; Marney and Nachmansohn, 1938; Augustinsson
and Nachmansohn, 1949; Koelle and Friedenwald, 1949 and Koe11e,
1950 and 1951).

Most of the acetylcholinesterase occurs in the post-

synaptic regions; although it is present at four sites in the junction:
1) the plasma membrane of muscle covering the junctional folds,
2} the prlrnal y and secondary synaptic
1

cl~fts,

3) the plasma me.mhra;ic

covering the terminal '· and 4) the vesicles of the terminal (Barrnett,
1962 and 1966 and Miledi, 1964).

The acetylcholinesterase catalyzes the

hydrolysis of ACh to choline and acetate, (Matthes. 1930 and Stedman,
Stedman and Easson, 1932). thereby reducing the activity of the transmitter at the cholinergic receptor by a factor of 1000 (Bacq and Brown,
H}37).

The ACh also acts at the nicotinic, cholinergic receptors {Langley,
190'/ and Bacq and Brown, 1937) which are located in the e. p. region of
the muscle fiber {Nastuk, 1953a; Del Castillo and Katz, 1955a and Ki:i.tz
and Miledi, 196la).

As the muscle membrane is impermeable to ACh

20.

(Del Castillo and Katz, 19~Sa), the receptors must be locate.cl on the
external surface of the muscle membrane. ' When ACh· activates ~ receptor;
r

.

"

the membrane resistance .d.ecreases (Katz; 1942 ·and Takeuchi.and Takeuchi,
-1960a), -dne to t..lle-simultaneous.-increase in-.permeability to both·sodiurn
and potassium

ions~

but not to chloride ions (Del Castillo and KatzJ 1954e;

Takeuchi and Takeuchi, 1960b and Takeuchi, 1963).

ACh does not carry

the current (Nastuk, 1953b and Del Castillo and Katz, 1955a).

Due to this

flo\v of sodium and potassium ions, the e. p. membrane potential
approaches the

e~uilibrium

potential of the muscle fiber - - 10 to 20

millivolts, negative (Del Castillo and Katz,
Takeuchi., 1959).

195~e

and Takeuchi and

·when the membrane potential reaches a c.ri.tieal depo-

larization- -threshold- -sufficient current flow is

e.stablisb~o

to activate

· the all or none processes of the muscle fiber (Ecclts, Katz an.ti Kufflef",
1941; Kuffler, 1942 and Fatt and Katz, 1951).

The action of the tra.nsm.itter

is very sho:ti and irr1pulsive (Eccles, Katz and Kuffler, 1941) and the level

of depolarization is determ1ned by the concentration of transtnilter in the

area of the choli11ergic receptor (Eccles and .Jaeger, 1958). When the
transmitter release is complete, the concentration of transmitfor falls,
rapidly, as it is inactivated by acetylcholinesterase (Marney and Nae htnansohn, 1938) or diffuses from the region of the e. p. (Ogston, 1955 and
Eccles and Jaeger, 1958). Then the e. p. p. passively decays in a logarithmic

------------·;··-------------------------21

fashion, until it returns to the resting membrane potential (Eccles, Katz
and Kuffler, 1941; Katz, 1942 and F'att and Katz, 1951).

Although the

e. p. is cbemically excitable, it is probably electrically inexcitable
_ . _(Werrnan,_ 1960).

Nor-mally, the e. p. p. is quite large and always initiates a muscle
action potential (KuffJ.er, 1942).

In order to record a pure e. p. p., it

i.s necessary to block the initiation of the muscle action potential.

This ·

can be accomplished by stimulating the nerve during a refractory state
or adrr1.·inistering (+)-tubocurarine (Gopfert and Schaefer, 1938 and Eccles
amt O'Connor, 1939 and 1941 ).

In this manner it is possible to study

nearomuscular transmission by studying changes in the extracellular
or intracellular e. p. p. (Fatt and Katz, 1951; Nastuk, 1953b and Del
Castillo and Katz, 1956).

The e. p. p. follows the stimulus after a period of latency - - the
synaptic delay.

The synaptic delay is not due to diffusion of transmitter

across the junction or to activation of the receptor substance.

It must

be due to a delay in the release of transmitter, probably involving the
electro·-secretory coupling process (Katz and Miledi, 1965a, 1965b,
1965d, 1967a, 1967c and.1967d).

22
Stimulation of the nerve sets up conditions in the motor nerve terminal

such that after the stimulus the probability of release is greater than in
the contro1 state (Feng, 1940; Eccles, Katz and Kuffler, 1941 and 1942;
Hutter, 1952; Liley and North, 1953; Lundberg and Quilisch, 1953a and
1953b; Brooks ,1956a and 1956b; Liley, 1956a and 1956b and Hubbard, 1959
and 1963).

This is referred to as post-activation potentiation (p.a. p.) or

post ... tetanic potentiation (p. t. p.) and occurs independently of release from
the conditioning impulse (Del Castillo and Katz, 1954c and Hubbard, 1963).
The quanta of transmitter (m) which a nerve impulse releases depends on
the number of quanta available for release (n) and the probability that a
single quahta will be released (p).
m

= np

(Martin, 1965)

During the period of post-activation potentiation· each quantum has a
greater probability of being released (Mallart and Martin,19£7 and 1968)
and under appropiate conditions will result in an increase in the quanta
released and a larger e. p. p. (Lundberg and Quilisch, 1953a and 1953b;
Del Castillo and Katz, 1954c and Liley, 1956b).
There are several mechanisms by which this change of m can occur.
The nerve terminal action potential has a positive (or hyperpolarizing)
after-potentia1 (Hubbard and Schmidt, 1961 and 1963) due to a prolonged
increase of potassium conductance (Gage and Hubbard, 1964 and 1966a).

23
According to Liley' s theory. this hyperpolc:rization would increase the
amplitude of the succeeding terminal spikes and increase the release of
transmitter (Eccles and Liley. 1959).
lation between

th~_tim~

But there

is not complete corre-

course of effects of hyperpolarization and the

increased release (Hubbard. 1959 and 1963; Hubbard and Willis, 1962a
and 1962b and Hubbard and Schmidt. 1962 and 1963).

Hubbard (1963)

observed two phases of facilitation, each due to increased release of
transmitter; and hypothesized that the early phase was due to mobilization
of transmitter to the release sites, while the secondary phase was the
result of a larger presynaptic spike from hyperpolarization.

Katz and Mil-

edi (1967b) observed that facilitation did not depend on a change in the
terminal action potential.

Gage and Hubbard {l966b) concluded that

post-tetanic potentiation was :1ot due to mobilization in the terminal.
They also eliminated several other possibilities, including presynaptic
swelling. increased intracellular sodium and decreased intracellular
potassium.

Changing the extracellula'r calcium ion concentration directly affects
the _r:Glcase of transmitter, as described previously.

Due to this pro-

nounced effect of calcium ion on release. it was suggested that residual
calcium intraterminally may account for facilitation {Katz and Miledi,
,'

24

1965e and Gage and Hubbard, 1966b).

Katz and Miledi (1967a and 1967c)

observed that the process of transmitter release continues to operate and
even increases during the falling phase of the- terminal action potential.
Calcium utilization occurs during the depolarization of the nerve terminal
(Katz and Miledi, 1967d) and facilitation is increased only when calcium
ions are present during the conditioning stimulus (Katz and Miledi, 1968).
Rahamimoff (1968) suggested that four calcium ions act at a receptor to
release one quanta of transmitter.

Facilitation would be expected to occur

if one or more calcium ions remain attached to the receptor until the

next impulse arrives.

Facilitation of the e. p. p. does not occur in all situations involving
more than one indirect stimulus.

When the muscle is blocked by

(+)-tubocurarine, the second e. p. p. of mammalian preparations-arid
subsequent e. p. p. s of amphibian preparations become depressed (Eccles,
Katz and Kuffler, 1941 and 1942 and Lundberg and Quilisch, 1953a).

This

depression has been shown to be due to a decreased quanta! content of the
test e. p. p. {Hutter, 1952; Perry, 1953; Del Castillo and Katz, 1954c;
Takeuchi, 1958a; Thies, 1960 and 1965; Brooks and Thies, 1962 and
Elrnqvist and Quastel, 1965).

Thesleff has shown some evidence for a

postsynaptic desensitizing action from accumulated ACh, as a result of
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the tetanus (Axelsson and Thesleff, 1958 and Thesleff, 1959); but these
results have been directly countered by others who show no evidence for
a desensitizing action during a tetanus (Otsuka and Endo, 1960a; Lilleheil
and Naess, 1961 and Otsuka, Endo and Nonomura, 1962).

It is possible

that a tetanic depression may be due to a propagation failure in the fine
nerve terminals (Krnjevic and Miledi, 1958 and 1959); but this type of
failure occurs only at high frequencies of stimulation and would be quite
obvious with unicellular recording techniques, if it did occur.

Evidence indicates that the decreased quantal content is due to a
depletion of the available stores of ACh (Perry, 1953 and Hubbard and
Kwanbunbumpen, 1968), even though there is an increased probability
of release during the depression (Elmqvist and Quastel, 1965 and Mallart

and Martin, 1968).

The results from the deficient calcium experiments

are different as they do not involve a depletion of the available store.
Thus they show only the increased probability of release (Mallart and
Martin, 1868).

In the in vivo experiments the muscle contracts supramaximally when
tetanically stimulated.

The tetanic contraction reaches a plateau and be-

gins to relax from the supramaximal contraction. Upon cessation of the
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tetanus, the twitch again becomes supramaximal-- p. t. p. of the twitch
(Guttman, Horton and Wilber, 1937; Rosenhlueth and Morison. 1937;
Feng. Lee, Meng and Wang. 1938 and Von Euler and Swank. 1940).
_The m1usual _aspect of this observation is the fact that the muscle can
contract greater than maximally.

This has been shown to occur upon

direct stimulation of denervated or curarized muscles with no change
in the gross muscle action potential (Brown and Von Euler. 1938 and
Von Euler and Swank. 1940).

Thus the supramaximal contraction involves

the active state of the muscle fibers and not the neuromuscular junction
(Hill, 1949; Macpherson and Wilkie, 1954; Ritchie and "Wilkie, 1955 and
Close and Hoh, 1968).

In the frog part of the p. t. p. of the twitch can be

explained by recruitment of quiescent muscle fibers (Grumback and Wilber.
1940), but this is probably due to the low safety factor of transmission in

some muscle fibers of the frog (Wakabayashi and Iwasaki, 1962).

This

would not be expected to occur in mammals which have a high safety factor
of neuromuscular transmission (Paton and Waud. 1967).

The tctanic depression is due to a decreased release of ACh. as a
result of depletion.

Thus many of the e. p. p. s are below threshold and

the gross muscle twitch becomes smaller (Dale. Feldbert and Vogt,
1936; Brown and Von Euler. 1938 and Li and Ting, 1941).

!""'.·
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When the motor nerve to a skeletal muscle is cut. the muscle becomes
inactive for a period of 12 to 15 days {Hines. Thomson and Lazere, 1942).
The distal nerve degenerates and loses its ability to initiate musde activity.·
At the same time there is a decrease in the ACh and ChAc activities
(Feldberg, 1943; Bannister and Scrase. 1950 and Berry and Rossiter, 1958).
The nerve completely degenerates leaving only the Schwann cells (Birks.
Katz and Miledi, 1960).

The m. e. p. p. s which had completely disappeared

shortly after sectioning the nerve. reappear after several days and must
originate from a site other than the nerve - - possibly the Schwann cell
(Birks, Katz and Miledi, 1960).

During degeneration the whole muscle

fiber becomes sensitive to ACh (Luco and Eyzaguirre. 1955; Axelsson
and Thesleff, 1959; Miledi, 1959 and 1960a; Frank. 1959; Jenkinson. 1960
and Katz and Miledi, l96lb) and there is a decrease in the acetylcholinesterase concentration around the original e. p. (Snell and Mcintyre, 1955
and Frank. 1959).

The distal stump of the regenerating neuron contains high concentration ;
of acetylcholinesterase and choline acetyl transferase, indicating that
these enzymes are produced by the nerve cell body (Sawyer, 1946; Hebb
and Waites, 1956 and Hebb and Silver, 1961).

The regenerating stump
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approaches the muscle fiber and induces the formation of an e. p.

Also,

there is a sensitivity decrease to ACh at the non-e. p. regions of the
t

muscle ·and an increase in the acetylcholinesterase concentration at the
e...p. .It has been concluded that this effect of the nerve on the .muscle is
due to a neural factor (probably not ACh) which is released and can induce
profound changes in the muscle fiber (Buller, Eccles and Eccles, 1960a
and 1960b and Miledi, 1960b and 1962).
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Drug-induced facilitation of neuromuscular transmission
Facilitation is defined as an increase in the twitch tension of an
indirectly stimulated skeletal muscle or antagonism of (+)-tubocurarine
paralysis.
drugs'.

Drugs which produce facilitation are termed 'facilitatory

The majority of these drugs have been shown to produce some

inhibition of cholinesterase.

As early as 1900, it was shown that physostigmine is capable of antagonizing neuromuscular paralysis induced by curare and this observation
has since been reported many times (Pal, 1900; Rothberger, 1901;
Rosenblueth, Lindsley and Morison, 1936 and Koppanyi and Vivino, 1944).
Also, physostigmine can facilitate the maximal indirect twitch of the cat
gastrocnemius muscle. It has no effect on nerve conduction and is
ineffective when the muscle is stimulated directly in a curarized or
denervated preparation.

The facilitation is associated with repetitive

action potentials in the muscle fibers, which occur at intervals near the
absolute refractory period of the muscle fiber.

This repetition acts

as a tetanus and induces a tetanic-like contraction of the muscle fiber,
resulting in facilitation of the muscle contraction (Brown, Dale and
Feldberg, 1936 and Brown, 1937).

ACh, administered close-arterially,

also elicits a brief, asynchronous tetanus.

Thus the drug-induced

repetitive firing is probably due to maintenance of transmitter
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at the muscle e. p.

As physostigmine is well known for its ability to

prolong the action of ACh by inhibition of cholinesterase and as it also

'

.

slightly increases the ACh contraction(Englehart and Loewi, 1930; Matthes,
1930 and Bacq and Brown, 1937), it seemed reasonable for the early

workers to conclude that physostigmine maintains transmitter levels at the
e. p. by inhibiting junctional cholinesterase.

Later studies using extracellular recording techniques in frog and cat
muscle, have shown that tubocurarine diminishes the a.mplitude of the
e. p. p. by competing with the transmitter at the cholinergic receptor
(.Jenki.rnrnn, 1960) but h:Js no effect on the time-course of the e. p. p.
·when the e. p. p. is decreased beJ.ow threshold by tubocurarine, it is
poss1.bh: to rec.ord a pure e. p. p. with no distortion from muscle action

potentials.

Aclr..:1inistration of physostigmine or neostigmine inereases

the amplitude and duration of the curarized e. p. p. (Feng, 1940; Eccles,
Katz and Kuffler, 1942 and Eccles and MacFarlane, 1949).

Physostigmine

a.lso prolong:.:> the active phase of the e. p. p. by a factor of two or three.
Thus the t:r:ansrnittcr is acting for a longer period of time at the e. p.
when pbysostigmine is present (Katz, 1942).

In a non-curarized preparation (refractory) physostigmine increases

~·

------------------------------------------•
the amplitude and time-course of the e. p. p.
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When the e. p. p. is longer

than the refractory period of the muscle fiber, repetitive discharges are
initiated in the muscle fiber.

Even in the presence of physostigmine the

fast e. p. p. is quite rapid, indicating that a physostigmine-resistant
mechanism of halting the action of the transmitter is occurring-probably
diffusion.

These results on the fast e. p. p. are compatible, and indeed broaden,
the theory of cholinesterase inhibition.

Thus it was hypothesized that

physostigmine and neostigmine by inhibiting cholinesterase prolong the
e. p. p .• such that repetitive activity is induced in the muscle.

The

repetitive activity gives rise to a tetanic muscle contraction.

Physostigmine also sets up a long secondary negative potential
change.

The secondary potential has a maximal amplitude of 40% of the

spike height and it may persist for a second or more.

This wave is

readily abolished by sub paralytic doses of curare which have little effect
on the fast e. p. p.

As these effects occur with no change in the muscle

membrane electric time constant,

and as tubocurarine has no effect on

cholinesterase inhibition in vitro, it is difficult to explain this action of
tubocurarine (Eccles. Katz and Kuffler, 1942).
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Although most of the previous results were compatible with the theory
that facilitatory drugs acted solely by inhibiting cholinesterase, n(me of
the experiments provided conclusive evidence that prolongation of transmitter action was due to cholinesterase inhibition.

Thus many workers

searched for evidence which would establish that cholinesterase activity

at the neuromuscular junction was. decreased during the action of the
facilitatory drugs.

The most common study involved correlating inhibition

of cholinesterase (such as, serum cholinesterase or electric eel cholin-

esterase) with the anticurare potency of these drugs (Bacq and Brown,
1937; EccJes, Katz and Kuffler, 1942; Bulbring and Chou, 19·17;

Blascho, Bulbring and Chou, 1949; Randall and Lehmann, 1950; Hobbigcr,
1952 and Karc~mar and Howard, 1955)

The results of these experiments

were quite conflicting, and the probable reason for the discrep<-.ncies was
brought

Otit

in a statement by Augustinsson (1959), "Plasma cholinesterases

arc regarded as a group of esterases with nrnch divergent properties with
regard to specificity against various choline and non-choline esters,
se:v:1sitivity to inhibitors and activity-substrate relationships. · · ·It is not
possible to apply results obtained with the plasma of one species to any
other species." This statement was well illustrated with muscle
cholinesterases by Blaber and Bowman (1962).

They reported that

ambenoniurn wcis 30 times as potent as neostigrnine in inhibiting cat muscle
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cholinesterase, but 1/200 as potent as neostigmine in inhibiting hen
muscle cholinesterase.

Thus conclusive experiments must involve a study

of the acetylcholinesterase of the neuromuscular junction and facilitatory
or anticurare.aGtion of a drug at a neuromuscular junction of the same
species.

If cholinesterase is previously inhibited, any drug which acts by

inhibiting cholinesterase should be ineffective.

Hobbiger (1952)

observed that previous inhibition of cholinesterase blocked the anticurare
action of the facilitatory drugs.

Neostigmine, applied iontophoretically,

blocked pote!ltiation of the ACh-potential by edrophonium (Katz and
Thesleff, 1957a}. Koelle (1957),

using the observation that physostigmine

pretreatment (Koster, 1946) or neostigmine pretreatment (Koelle, 1946)
protected cholinesterase from irreversible inhibition by DFP,

observed by

histochemical methods that ambenonium and methoxyambenonium in
concentrations, which were pharmacologically active, protected the
junctional cholinesterase from DFP inhibition.

These results indicated

that ambenonium and methoxyambenonium were inhibiting junctional
cholinesterase when they antagonized curare; but as stated by Koelle (1957)
this does not show that cholinesterase inhibition was the important mechanism of action.
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The facilitatory drugs cause not only potentiation of the neuromuscular
-·

~.

.

-

twitch, but also depression at high doses (Bacq and Brown, 1937; Rosenblueth and".l\1orison, 1937;· Van Der Meer and Meeter, ·r956b arid Riker,
--Roberts, Standaert and Fujimori, .1957) .. In toxicity .studies-this dep:r·ession
appeared to be due to cholinesterase inhibition {Bodansky and Mazur, 1946 ·
and Nachmansohn and Field, 1947).

TEPP, tetraethylpyrophosphate, cause

a depolarization of the e. p. at high doses, but was not capable of eliciting
a twitch ~t any dose level.

Thus Douglas and Paton 0 9 54) concluded that

TEPP induced depression of the e. p. by inhibiting junctional cholinesterase.
Yet many workers have shown that total inhibition of cholinesterase did not
block the indirecrr.vitch (Berry and·Ev:ons,

H!~l;

Barnes and Duff, 1953;

Barstad, 1956b and Van Der Meer and Meeter, 1956a).

Douglas and

Matthews (1952) observed that TEPP blockade was readily reversible,
even though TEPP was an irreversible cholinesterase inhibitor.

On the

basis of this type of data Barstad (19 56a) concluded that DFP, in addition

to its cholinesterase inhibiting properties, also exhibited a curare-like
adion at the e. p.

The theory of cholinesterase
generally accepted until 1946.

inhibition by facilitatory drugs was

Then Riker and Wescoe (1946) observed

that neostigmine produced a contraction of skeletal muscle, even though
the acetylcholine.sterase was previously inhibited by DFP- -
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diisopropylphosphofl.uorddatc;, a very potent. irreversible cholinesterase
inhibitor (Mazur and Bodansky. 1946; Mackworth and Webb, 1948 and
Michel and Krop. 1951).

They concluded the primary effect of neostigmine

. ~was a direct, depolarizing action (like ACh) at the e. p. and did not
involve cholinesterase inhipition.

Several analogues of neostigmine.

including 3-hydroxy phenyltrimethylammonium (3-0H-PTMA). which
facilitated the neuromuscular twitch and antagonized tubocurarine blockade of the twitch. also stimulated denervated muscle.

As 3-0H-PTMA

lacked the carbamate grouping which was responsible for cholinesterase
inhibition {Stedman. 1926). Riker concluded these compounds acted via a
direct, stimulatory action and that other facilitatory drugs had the same
mechanism of action (Randall, 1950; Randall and Lehmann, 1950 and
Riker and Wesco<:,1950).

Edrophonium {3-hydroxy phenyldimethylethylammonium) was more
specific than neostigmine in its anticurare action at the neuromuscular
jundion--it had fewer cholinergic side effects.

Randall and Jampolsky

(1953) hypothesi?.ed that neostigmine acted by cholinesterase inhibition,
while edrophonium acted by a direct, stimulatory action on skeletal muscle.

Smith, Cohen, Pelikan and Unna {1952) observed that neostigmine,
physostigmine and edrophonium exhibited direct stimulatory effects on the
----·~·

____ ____________________________________________,_,,_..
.._
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frog rectus preparation which were 1/ 560, 1/ 75, 000 and 1/216 as effective.
respectively. as ACh.

These drugs were at least one-thousandtih1.es as

effective in potentiating an·ACh contracture. as in producing a direct,
. stimulatory effect.

Furthermore there_ was no correlation between the

stimulatory effect and the potentiation of ACh contractures.

They conclude9

that the effects of the facilitatory drugs on the frog rectus could not be
due to a direct, stimulatory actiori.

Edrophonium did not depolarize the muscle e. p. except at concentrations which were much higher than those necessary to produce
facilitation of the muscle twitch in the frog (Nastuk and Alexander, 1954).
Katz and Thesleff (1957a}, using microelectrode iontophoretic
techniques, applied A Ch to a frog muscle e. p.

If minimal doses of

edrophonium were applied, the ACh-potential was augmented.
dose of edrophonium, alone, produced no depolarization.

This same

Only at much

highc.t" doses was edrophonium cap2.ble of depolarizing the e. p.

Also,

ech ophonium did not potentiate a depolarization due to carbachol { a

stable choEne ester}, as would be expected if edrophonium was acting
by a direct, depolarizing action.

These results could only be explained by

t.be theory that edrophonium inhibited cholinesterase.

Although it was not

possible to determine what concentration of edrophonium was necessary
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to inhibit cholinesterase, these results were the first to show conclusively
that acetylcholinesterase inhibition at the neuromuscular junction .
produced a physiological effect- -prolongation of the action of A Ch.

Randall (1950) and Riker (1953) suggested that displacement of tubocurarine from the e. p. receptor could explain the antagonistic action of
edrophonium.

Yet when tubocurarine was displaced from the receptor

by rinsing the muscle in non-curarizedRinger, the amplitude of thee. p. p.
was augmented with no change in time-course.

Edrophonium increased

both the amplitude and time course of the e. p. p. (Nastuk and Alexander,
1954).

Succinylcholine, like decamethonium, acted at the mammalian neuromuscular junction by depolarizing the muscle e. p. (Burns and Paton,
Initially this depolarization increased the

excitability of the

muscle, such that facilitation of the muscle twitch occurred.
prolonged depolarization, there was a
muscle twitch (Zaimis, 1951).

After

secondary depression of the

Methoxyambenonium was capable of

antagonizing depolarization block by succinylcholine and decamethonium
(Karczmar, 1957) and competitive block by tubocurarine (Lands, Karczmar,
Howard and Arnold, 1955).

These results seemed to contradict the

. ·classical theory of neuromuscular pharmacology- -blocking drugs must
act by depolarization or competition, and depolarizers and competitors
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are mutually antagonistic.

In. addition pretreatment with methoxyambenoff:-

ium increased the succinylcholine facilitation, but decreased the secondary
blockade.

,

.

.

Karczmar (1957 and 1961) stated that the underlying mechanism

of neuromuscular facilitation was more complex than originally thought
and "may depend on more sites of action. "

ACh was known to have a desensitizing action in isolated amphibian
preparations (Thesleff, 1955a, 1955b and 1958 and Axelsson and Thesleff,
1958) and methoxyambenonium readily restored the sensitivity of
muscles which had been desensitized by ACh (Kim and Karczmar, 1967}.
Thus a sensitizing action which had been hypothesized for other facilitatory drugs (zaimis, 1951; Cohen and Posthumus, 1955 and Van Der Meer
and Meeter, 1956b} was hypothesized by Karczmar, Kim and Koketsu
(1961) to be involved in the mechanism of action of methoxyambenonium.

This theory was countered by other evidence.

Edrophonium was not

capable of potentiating the depolarization from an iontophoretic application
of carbachol (Katz and Thesleff, 1957a).

Blaber (1960) observed that·

methoxyambenonium and ambenonium exhibited curarimimetic properties
at doses higher than were necessary to antagonize tubocurarine.

Thus it

was concluded that antagonism to depolarizing block was due to this
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curarimimetic activity and not due to sensitization.

This was further

supported by the observation that succinylcholine blockade was an,tagonized
by appropriate mixtures of neostigmine and tubocurarine (Blaber and
Karczmar,-'1967a and1967b).
Masland and Wigton (1940) investigated the origin of spontaneous
twitching which occurred after administration of facilitatory drugs (Langley
and Kato, 1915).

Upon administration of neostigmine, spontaneous

antidromic action potentials and antidromic potentials after an indirect
stimulus were recorded in the ventral root of the cat spinal cord.

Masland

and Wigton concluded that the antidromic impulses originated in the region
of the motor n.e:rve endings.

As ACh also produced the spontaneous activity

in the nerve it seemed likely that neostigmine acted by causing an
accumulation of ACh at the neuromuscular junction, thus allowing ACh
to act at the nerve endings (Eccles, 1964 and Hubbard, 1965).

Physostigmine also produced antidromic activity in the cat.

Feng

and Li (19,11) co:1clnded that physostigmine acted directly on the
presynaptic nerve endings in the mammalian preparation.

Yet there was

not complete correlation between repetitive firing of the nerve and
repditive firing of the muscle.

Due to this inconsistancy, it seemed

likely that the nerve terminal was not the site of drug action, but was
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merely stimulated by the prolonged e. P~ current in the presence of
physostigmine (Eccles, Katz and Kuffler, 1942).

Antidromic activity

was obvious in the nerve following direct stimulation of the muscle.
After indirect stimulation the repetitive activity of the muscle appeared
to occur earlier than the repetitive activity in the nerve.

Also, antidromic

activity occurred in.nerves which were not stimulated and was· decreased
when the, nerve stimulus was desynchronized.

These results indicated

that muscle action potentials were capable of depolarizing the nerve
terminals, such that antidromic activity was initiated.

This depolarization·

of the nerve terminal in turn induced repetitive activity in the muscle,
resultjng in a tetanic-like twitch (Lloyd, 1941 and 1942 and Brown and
Matthews, 1960).

According to these theories all the effects of

physostigmine can be explained on the basis of in'hibition of junctionaJ
cholinesterase.

Barstad (1962} observed that antidromic nerve discharges could
be elicited t:ven though the muscle fibers were cut and could not respond
to a stimulus.

Upon more careful examination, two types of

antid~omic

11crve activity were observed by Werner (1960a, · 1960b and 1961) in the
presence of the facilitatory drugs.

The early phase had a very short

latency and was due to the ephaptic backfiring from the muscle action

potentials as described by Lloyd and Brown and Matthews.

But there was

also a secondary phase of antidromic activity which had a longer latency.
This secondary phase could only be explained by the theory that a long
generator. potential occurred in the .motor -nerve terminal (Werner, 19 60b).
This generator potential probably was the negative afterpotential of the
nerve terminal spike.

Thus paired stimuli with a short interval increased

the antidromic activity in the nerve and paired sUmuli of a long interval
depressed antidromic activity in the nerve (Werner, 1960a and Blaber
and Bowman, 1963b}.

This theory was supported by the observation

that antidromic activity which occurred in unstimulated nerve fibers had
a short latency.

The secondary activity, which had a longer latenc:y,

occurred only in nerve fibers which had been stimulated ·(Werner, 1961).

There was one discrepancy in these results.

Werner (1960a) by

using paired stimuli concluded that the negative afterpotential of the motor
nerve terminal had a duration of only 5 msec.

Yet the antidromic activity

after an orthodromic stimulus in the presence of a facilitatory drug had
a much longer duration; thus Blaber and Bowman (1963b) concluded that
the negative afterpotential was also longer.

The short duration observed

by \Verner (1960a) was probably due to extinction of orthodromic stimuli
by antidromic stimuli (Blaber and Bowman, 1963a}.
>

'

Hubbard, Schmidt

and Yokota (1965) also observed a longer duration for the negative
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afterpotential of the motor nerve terminal.

Pentobarbital, procaine and cyclopropane blocked antidromic nerve
activity induced by 3-0H-PTEA (3 hydroxyphenyltriethyla...mmonium), but
these anesthetics had no effects on the facilitation of neuromuscular twitch
which was produced by 3-0H-PTEA {Riker, Werner, Roberts and
Kuperman, 1959).

Thus the nerve terminal generator was distinguished

from the muscle generator of repetitive activity.

Tubocurarine blocked

the nerve terminal generator potential at lower doses than it blocked
the ephaptic activity.

On the basis of these results it was concluded

that the safety factor for axonal excitation by the terminal generator was
narrow·er than the safety factor for transmission to postSynaptic units
(Werner, 1959 and 1961).

The facilitatory drugs produced facilitation of the mammalian
neuromuscular twitch, rather easily.

The amphibian muscle was much

less respon_sive to the actions of these drugs (Raventos, 1937), although
it was possible to produce facilitation of the amphibian muscle twitch
with physostigmine or edrophonium, when a stimulus rate no greater
than one per minute was used {Feng, 1937; Hodes and Steiman, 1939
·and Nastuk and Alexander, 1954).

This difficulty in obtaining facilitation
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was paralleled by a lack of antidromic activity in the presence of the
facilitatory drugs (Dun and Feng, 1940).

These results may point to a

fundamental difference in the pharmacological action of the facilitatory
drugs at the mammalian as compared to the· amphibian neuromuscular
junction {Blaber and Karczmar, 1967b).
Riker and co-workers (1957) began an investigation of the nerve
terminal activity of a series of phenolic compounds.
wer~

These compounds ·

structurally similar to neostigmine. except they were considerably

less potent than neostigmine in inhibiting acetylcholinesterase. 3-0H-P'IMA ·.
facilitated the neuromuscular twitch at low doses and blocked the neuromuscular twitch at high doses.

When the hydroxyl group was eliminated,

as in PTMA (phenyltrimethylammonium) or PTEA {phenyltriethylammonium ,
the ability to facilitate the twitch was lost.

As 3-CH3-PTMA (3 methyl-

phenyltrimethylammonium) was ineffective. the ability to facilitate the
twitch seemed to require the presence of a hydroxyl or carbamyl grouping
in the meta position.

The meta grouping was also necessary to initiate

antidromic activity in the motor nerve.

On the basis of these results

Riker, Roberts, Standaert and Fujimori (1957) concluded that
3-0H PTMA and its analogues which also facilitated the twitch produced
their facilitatory effects by an action on the motor nerve terminal
(Kuperman, Gill and Riker, 1961).

As the ethyl analogues showed
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no depression, they further concluded that the depressing activity was due
to depolarization and was related to the number of methyl groups on the

'

'

quaternary nitrogen (Randall, 19 50 and Smith, Cohen, Pelikan and Unna,
1952).

Edrophonium, ambenonium and neostigmine facilitated the neuromuscular twitch and induced antidromic activity in the ventral root.
Mcthoxyambenonium depressed the sensitivity of the e. p. and nerve termina
and probably, for this reason could not facilitate the muscle twitch or
induce antidromic nerve activity (Blaber, 1960).

Goode, Blaber and

Karczmar (1965), using Koelle's (1957) technique, observed that it was
possible to facilitate neuromuscular transmission with doses of edrophonium and neostigmine which did not protect cholinesterase from inhibition
by DFP.

This may indicate another mechanism of action for these drugs

although such a conclusion, at least with edrophonium was not completely
justified as kinetic studies have shown that inhibition of cholinesterase by
edrophonium was very rapidly reversed, and therefore could not be
expected to protect from DFP (Wilson, 1955 and Katz and Thesleff, 1957a).

Intravenous edrophonium and close-arterial edrophonium and
neo~~tigmine

facilitated the neuromuscular twitch but did not increase the

contracture from close-arterially injected ACh.

Methoxyambenonium
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(intravenously or close-arterially) antagonized tubocurarine but did not
augment the ACh-contracture.

If the facilitatory d:rugs acted by inhibiting

junctional cholinesterase, the ACh-contracture and indirect muscle twitch
should be increased at the same dose.

Furthermore, there was rto corre-

lation between facilitation or anticurare action • and the cholinesterase
inhibiting acUvity of these drugs.

On the basis of these results Blaber

and Bowman (1959 and 1963a) and Blaber (1960 and 1963) concluded that the
facilitatory drugs produced their effects by a direct action on the motor
nerve terminal.

The development of unicellular recording techniques opened a new
realm in which to study the effects of drugs at the neuromuscular junction.
Fatt and Katz (1950 and 1952) in their early experiments in the frog
observed that neostigmine increased the amplitude and half-decay time,
but not the frequency of m. e. p. p. s.

As hypothesized by Katz (1958 and

1962) experimental changes of m. e. p. p. time-course involve a postsynapUc rnechanism while experimental changes of m. e. p. p. frequency
involve a presynaptic mechanism.

Liley (1956a) reported similar obser-

vations vvith neostigmine in the rat diaphragm, but Boyd and Martin (1956a)
observed small increases in the frequency of m. e. p. p. s in the cat
tenuissimus.
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Neostigmine augmented the amplitude of a curarized e. p. p. (Fatt
and Katz, 1951 and Boyd and Martin, 1956b) but produced relatively
small changes in the time-course.

Neostigmine greatly prolonged the

time-course of an e. p. p. which was recorded in a ringer solution that had
20% of the control sodium ion concentration (Fatt and Katz, 1951).

IncreasN

of the e. p. p. were accompanied by proportional increases in e. p. current
(Takeuchi and Takeuchi, 1959).
Several drugs have been shown to produce effects on the e. p. p. which
are very similar to those reported for neostigmine, but these drugs do not
act by inhibiting junctional cholinesterase.

TEA(Stovner, 1958 and

Koketsu, 1958), guanidine (Otsuka and Endo, 1960b) and phenol (Otsuka and
Nonomura, 1963) have been s_hown to increase the release of transmitter.
Thus the present investigation will be undertaken to try to determine the
mechanism by which the facilitatory drugs produce their effects at the
neuromuscular junction.

The drugs which will be used are: l)ambenonium,

a very potent acetylcholinesterase inhibitor; 2) neostigmine, a classical
facilitatory drug; 3) edrophonium, a potent facilitatory drug which has
been reported to be a very weak acetylcholinesterase inhibitor and 4)
methoxyambenonium, a potent antagonist of tubocurarine blockade that is
not able to facilitate the maximal muscle twitch.
.

'

cholinesterase inhibiting properties.

It also has weak acetyl-

.
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METHODS
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I.

Anatomy of the Tenuissirnus Muscle of the Cat
All experiments were performed on the tenuissimus muscle of the cat.

This muscle was chosen as it. is very similar pharmacologically to the
gastrocnemius and tibialis muscles which have been used in in vivo studies
(MacLagen. 1962). The tenuissimus muscle originates from the transverse process of the second caudal vertebra.

It lies between the biceps

femoris and semimembranous muscles in the sciatic notch and inserts on
fascia of the shank (Hyman. 1962). As the tenuissimus muscle is quite
long ()5 cm.) and thin (1 mm) it makes a very good isolated tissue
preparation.
whiclJ. i::> :o.ot

Ringer solution can reach most of the fibers in the muscle,
~.i:ue

gastrocnemius.

of such large muscles as the tibialis o.ntcrior a;.-1d
The tenuissimus nerve arises from the sciatic nerve.

Just before entering the tenuissimus muscle. the nerve trunk divides - one branch passing anteriorly and the other branch passing posteriorly - and enters the muscle.

Each branch passes superficially down the middle

of the muscle giving off nerve fibers to the muscle fibers.

It.

Removal of Muscle
Cats were anesthetized with 70 mg/kg alpha-chloralose intraperitoneall .

5 mg/kg pentobarbital sodium facilitated induction and 1. 5 mg/kg atropine
aided in blocking mucous secretions.

The sciatic notch was
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opened to expose the tenuissimus muscle and nerve.

The tenuissi.mus

nerve was dissected free from the sciatic nerve so that a segment of nerve
about 3 cm long could be obtained.

The muscle was then dissected free.

In general, the distal portion of the

mu~cle

was used in the experimental procedure.

(below the entry of the nerve)

The muscle was placed in a

muscle bath .. Removal of connective tissue from the muscle made it
possible to see the superficial nerve fibers with the aid of a microscope.
Pinning the muscle securely to the bottom of the bath eliminated extraneous movements.

The ends of the muscle were then cut distal to the pins.

The nerve was placed over the bipolar platinum electrodes (5mm apart)
in a separate compartment of the bath (except in m. e. p. p. studies when
the nerve was not removed from the animal).

III. Perfusion of Muscle
Krebs solution was used to supcrfuse the isolated tissue.

All reagents

except NaCl,. D-glucose, and NaHC0 3 were kept in stock solutions.

Thus

addition of 2 ml of each of the stock solutions to a liter of distilled water
gave the proper concentrations (Table 1) (Boyd and Martin, 1956a).
NaCl, D-glucose, and NaHC03 were measured as dry weight.
solution was aerated with 95%

o2

and 5%

co 2 through a

The

This

sintered glass

aerator in a 50 ml bath before passing into the isolated muscle bath.
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Table 1

·· · -········Composition of the Kreb's solutfon superfusing
the isolated tenuissimus muscle.

115 mM

NaCl

4. 60 mM

KCl
KH2P0 4

1.15 mM

NaHC0 3

24.1 mM

Cr·d. C'l
, 2

2. 46 mlVI

JVIgS0 4

1.15 mM

Glucose

Il~.__:·x..: ~~~~-~·.~:,~ ~~+-..~ ~~..cm:::z.&:
..

..

..

.....

8. 85 mM

~~~-~~~~"
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(Another bath was used for drug-Krebs solution. ) The 50 ml bath had a
wann water jacket, controlled by a Haake constant temperature

circu-

f'

lation pump. so that the temperature of the Krebs solution was raised to
.. zpproximately 40°G•...The Krebs .solution then flow_e.d___int.o tn_e __m~s_cle
bath via a narrow diameter (PE 90 - I. D. 0. 034 11 , O. D. 0.. 050") polyethylene tubing of approximately 16 inches in length.

The tubing also ran

through a warm water jacket again to reach a constant temperature before
entering the muscle bath.

The polyethylene tubing was placed in the

muscle bath and the Krebs solution was allowed to run freely into the
muscle bath.

The flow was constant for any experiment (200-250 ml/hr)

and was determined by the length of polyethylene tubi.ng and height of the
50 ml bath.

The temperature was constant {it depended mainly oi: flow

rate) but could. be varied by a temperature control on the circulation
pump such that the final temperature in the muscle bath was constant at
approximately 37°C (36-38°C).

The muscle bath had the following dimensions - - 0. 6 cm x 8. 0 cm
x O. 5 cm.

The nerve compartment measured 1. 0 cm x 1. 0 cm x 0. 5 cm.

Thu_s the total volume of the bath was approximately 3 ml.

This allowed

for rapid turnover of solutions { 2x volume in 1. 5 min. ) with a minimal
amount of movement.

The solution was removed by overflow into a drain.
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The only adjustment necessary to change to new solution was to move a
clamp from one tubing to another.
constant throughout the experiment.

The rate and final temperature were
A muscle could be maintained for

at least 10 hours without significant decay of membrane potential

or

neuromuscular transmission.
IV. The Making and Filling of Electrodes
Microelectrodes were made from pyrex capillary tubing (0. 1 cm
diameter - 7 cm length)

The tubing was pulled to a narrow tip with a

David Kopf #700 vertical pipette puller using nichrome heater coils.

The

electrodes were floated on distilled water and examined under a microscope (lOOx magnification factor) to obtain a rough estimate of the tip
size (determined by distance water passes up electrode) and general
contour of the tip and shank of the electrode .. Only those electrodes with
narrow tips (little water passing in) and narrow shanks were filled.
others were discarded.

A 11

The electrodes were then boiled in filtered

methyl or ethyl alcohol for 3 minutes using a Precision Scientific
vacuum pump to fill the electrodes with alcohol.

The alcohol was then

replaced with distilled water by immersing the alcohol filled electrodes
in filtered distilled water for 30 minutes.

Finally, the electrodes were

immersed in filtered 3M KCl until the day of use (at least 24 hours).
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When electrodes were made for iontophoretic studies, they were immersed

in ACh or carbachol (0. 3 M to 3M), rather than KCl.

By storing in a

refrigerator, these electrodes were usable for periods up to several months

V.

Recording Appartus
Recordings were made using the intracellular technique developed

by Ling and Gerard (1949) and Nastuk and Hodgkin (1950).

The electrode.

was supported in a glass tubing (I. D. 0. 2 cm) which was filled with an
agar - 3 M KCl column.

The agar - 3 M KCl column made connection

with a silver chloride coated-silver wire spiral to eliminate a junction
· potential.

Ail indifferent electrode which made contact with Krebs

solution consisted of an agar ,.. Krebs column in contact· with a silversilver chloride spiral wire.

(The silver wire spiral was coated with

silver chloride by electrolysis in 0. 1 N HCl.

(2Cl- + Ag

----+

AgC1 2 + 2 e:-.)) The.-two-inputs (one from each agar bridge) were
connected to a Nikkon hi-input impedance amplifier.

The output of this

pre-amplifier led into a Tektronics Type 502 dual beam oscilloscope.
This trace was used to monitor the membrane potential of the muscle cell.
A second output from the preamplifier led into a Tektronics Type 122
low-level preamplifier.
dual. beam oscilloscopes.

This output led into two Tektronics Type 502
r_r:he first oscilloscope which was monitoring

..•.
t>C
PreQ.tv\f'lifler

AC
Preamplifier

Recordin3
Osei llor.cope
J.f7 K.Q

i

WQ.rM Lc.la.ter
JQ.cket
DIAGRAM OF PERFUSION AND RECORDING APPARATUS

. __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _,_ _,...__________,_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _. _ l
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the membrane potential (low gain) was also used as a monitoring scope
for the end-plate phenomena (high gain).

The second oscilloscope had

only the end-plate phenomena and was used for recording purposes.
Permanent records were made with an Analab oscilloscope camera.

Thirty

five millimeter still or continuous motion pictures could be taken of the
potentials depending on the particular experiment.

VI.

Selecting an Electrode
Electrodes were selected on the basis of their resistance and abiiity

to penetrate the muscle fiber without causing considerable damage.
general, a resistance of less than 20

[n

megohms was necessary to make::

the noise level sufficiently small to record miniature potentials.

If the

resistance was less than 5 megohms, the electrode tip was usually too
large and therefore damaged the muscle fiber.

After an electrode of t11e

correct resistance had been obtained, the electrode was placed in several
rr:uscle fibers.

If the electrode gave a deflection equivalent or greater

than 60 m V and there was no significant decay of the resting membrane
potential, ihe electrode was considered usable.

If there were no

deflections of greater than 60 mV for resting membrane potentials, or
the resting membrane potenticil decayed constantly, the electrode was
discarded. An AC square wave signal was passed through the electrode

-----------------------·----------------------------------------------------.
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and by means of a capacity compensator in the Nikkon hi-input impedance
amplifier, it was possible to keep the time-constant of the system below
70 µsec.

VII.

Locating an End-Plate and Recording M. e. p. p. s
Connective tissue on the surface of the muscle was removed to expose

the nervous structure of the muscle (small superficial branches come
off a large central nerve).

The superficial nerve branches were located

with the aid of a binocular stereo microscope (magnification - 15x).

The

microelectrode and indifferent electrode were carried on a Narishige
micromanipulator.

The microelectrode was generally inserted in the

area of a small superficial nerve.
locating an e. p. was quite high.

As a result, the prob.ability of

The presence of m. e. p. p. s indicated

that the electrode was near the e. p. region of the muscle.

'The electrode

was usually reinserted into the muscle until a point was found where the
m. e. p. p. s were of maximal amplitude and shortest time-course.

'The

resting membrane potential was also recorded to show that the muscle
fiber was in good condition and not decaying over a long time period.
Pictures of them. e. p. p frequency were taken on a slow sweep (O. l cm/sec)
and tirne course were taken on a rapid sweep ( 2 msec/ cm).
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VIII.

Locating an End-Plate and Recording (+)-Tubocurarine, High
Magnesium and Benzoquinonium E. p. p. s
The nerve to the tenuissimus muscle was placed over bipolar platinum

electrodes (0. 5 cm apart) in a separate compartment of the bath.

The

nerve was stimulated at 2 x maximal voltage with a pulse of 50psec at a
rate of 1/2. 5 to 1/10 stimulus per second.

The muscle twitch was blocked

by tbe lowest possible concentration of (+)-tubocurarine (2 to 5 pg/ml),
benzoquinonium (1. 5 to 3 pg/ml) or decreased calcium and increased
magnesium.

The blocking agent was added to the Ringer solution and
~-

infused through a second 50 ml bath system.

An

a manner similar to that for the m. e. p. _µ. s.

Amplitude was the major

criteria.

p. p. was localized in

An amplitude of greater than 3 mv was genera1ly used (except

in quantal content studies).

The half-decay was usually below 2 msec

(rise to one-half fall) and the rise-time was less than 1 msec.

This e. p. p.

was then used as control for drug-induced effects.
IX. Iontophoretic Application of Drug§
In this series of experiments the recording apparatus was the same as
previously described, except only DC-amplification was used.
twitch was always blocked with (+)-tubocurarine (4 pg/ml).

The muscle

The

iontophoretic electrode (with A Ch or carbachol) was supported in a
~ccond mj

cromanipulator.

Two stimulators were necessary, one to
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eject the drug and ci.notber to retard diffusion of the drug from the tip of the
eiectrode.

Each stimulator was connected to an.isolation unit.

The two

isolation units were connected in series, with one lead from the isolators
_pas.~ ing_ thr9_ugt~__ _a.

2_q_ m~_g()hI?

r_~Ej~S-~~~c~__in!o_ t?e..-----------·--iontophoretic
electrode._
_____
·-- ----··
.
,

,

The other lead passed through 47 kohm resistance into the bath .. The end
of each lead was coated with silver chloride.

By recording the voltage

change across the 47 koh:in resistance it was possible to determine the
amount of current {as ACh or carbachol) which passed from the electrode.
This current recording was used as a monitor to be certain that equal
dosE:s of drug i.,vere ejected with each pulse.

After an e. p. p. had been located, the iontophoretic electrode
moved into the region of the e. p.

\V8.S

By careful manuevering of this

electrode, it was possible to produce a rapid depolarization of the e. p.
from application of ACh or carbachol.

These drug-induced potentials

remainea relatively constant fri amplitude and time-course.

Rapid

iontophoretic potential.s {half-decay less than 100 msec) required precise
localization at the e. p.

Any movement produced large changes in the

iontophoretic potential.

As these experiments required long infusion times,

it seemed desireable to use slower potentials {100 to 500 rnsec half-decay).
Then movements were not so critical.

The pulse voltage and duration for
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drug ejection were varied such that the amplitude of the iontophoretic
potential was similar to the amplitude of the e. p. p.

The braking current

(opposite polarity) was adjusted, such that no decay of the membrane was
obvious from diffusing drug.
X.

Infusion of Facilitatory Drugs
The agents used were neostigmine bromide, edrophonium chloride,

ambenonium chloride, and methoxyambenonium chloride.

The facili-

tatory drug was added to a volume of the control Krebs-Ringer solution
and infused through a second 50 ml bath.

The initial concentration of the

facilitatory drug was 10 -B M (except in the case of ambenonium where
due to its high potency, the initial concentration was 10

-10

~M

or 10

-1'>

""M)

and the concentration was increased by IO times every 15 - 20 minutes
until a predominate postsynaptic action occurred - twitching, depolarizing
(decreased amplitude and decreased resting membrane potential) or
competitive blockade (decreased amplitude but no effect on the resting
membrane potential).

The muscle was then returned to a control Krebs-

Ringer solution to determine if the drug was reversible or irreversible.
Drugs were infused for a period of ten minutes before recordings were mad

XI.

Measuring the End-Plate Phenomena
The film which had been exposed to the e. p. phenomena was projected

on a Durs.t, 606 Enlarger such that the potentials were magnified 2. 5x in
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__ .order to make the necessary measurements.

M. e. p. p. frequency was determined from a series of traces which were
fihned at a sweep speed of 0.1 sec/ cm or I sec/ sweep for a period of 25
seconds.

Five such samples were taken at 2 minute intervals for each

experimental situation.

The standard error of the five samples was

calculated as well as t-values for significant changes due to the drugs.

M. e. p. p. time-course was recorded on fast multiple sweeps (2
msec/ cm) by holding the camera shutter open until a m. e. p. p. occurred
on the monitor scope.

This resulted in a thick base line.

In each

experimental situation, 10 m. e. p. p. s were measured for 1) amplitude,
2) rise-time, and 3) half-decay time and the average was calculated.

E. p. p. s were also recorded on a fast sweep (2 msec/ cm) which
could be triggered to give a single sweep.

Again the 1) amplitude, 2)

rise-time and 3) half-decay time were measured from ten samples in
each experimental situation.

In iontophoretic studies e. p. p. s and iontophoretic potentials were
recorded on single, slow sweeps (100 to 500 msec/ cm). 1) E. p. p. amplitude and iontophoretic potential 2) amplitude 3} rise time

and 4) half-

decay time were measured from five records for each experim;ental
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condition.

Standard deviation and t-values were calculated for each group of
samples.

The effect of facilitatory drugs on quantal content was calculated from
the number of e. p. p. failures during 200 nerve stimuli with decreased
c~lcium

(O. 9:?nM) and increased magnesium (5-7 mM)

ion concentrations

or by comparing the amplitudes of 50 m. e. p. p. s and 50 e. p. p. s with
increased magnesium ions (12-15 mM) (Del Castillo and Katz, 1954c).
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RESULTS SECTION 1

EFFECTS OF FACILITATORY DRUGS ON
M. E. P. P. SAND (+)-TUBOCURARINE E. P. P. S.
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INTRODUCTION

'

Several microelectrode techniques are commonly used to dis tinguish presynaptic and postsynaptic

~echanisms

of drug action.

The

most direct technique involves the effects of drugs on m. e. p. p. frequency
and time-course (Katz, 1958, and 1962). Also, a comparison of the

ampl~-

tude and time-course of m. e. p. p. s and e. p. p. s, and observation of the
e. p. membrane potential at various drug concentrations should enable a
distinction between: 1) a direct, depolarizing action,
the e. p. receptor,
action.

2) sensitization of

3) cholinesterase inhibition and 4) a pre-junctiona1
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RESULTS

Effects of neostigmine on m. e. p. p. s
The effect of neostigmine on m. e. p. p frequency was to produce a
small but significant increase in three out of four experiments.

The

effects on frequency were not readily reversible and the frequency remained at the increased level after the muscle had been returned to
Krebs solution for 90 minutes.

No effects on amplitude or rise-time were noted when the perfusion
solution contained 10- 8M neostigmine.

7
With 10- M neostigmine. the

increase in both the amplitude and the time course became very significant
(P'= O. 001) and the parameters were further increased by 10- 6 M neostig-·
mine.

With 10-5M the amplitude and time course of m. e. p. p. s. decreased

as the membrane potential fell from 60 to 39 mV.

6
At 10- M the amplitude

increased by 67%. the rise-time by 86% and the greatest increase was the
half-·decay which increased by 188%.

The effects on amplitude and time

course, and the depolarization of the end-plate membrane were all
reversed after returning the muscle to Krebs solution for 90 min.

An

example of the effects of the neostigmine on m. e. p. p. s. is given in
Table 2A.

TABLE 2A

Effects of Neostigmine on M. e. p. p. s.

Concentration
of
neostigmirie (M)
Control
10-8

Frequency
of
m. e. f,· p. s
(sec- )a:

'

.

Amplitude
(mV)b

I
i

Rise-time
(msec)b

Ealf-decw
(msec)

'
Membrane
potential
(mV)

1. 9+0. 4

. o. 6+0. 1

0.7+0.l

0.8+0.2

c

0.7+0.2

o. 7+0. 1

o. 9_:!:0. 3 i
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T

10- 7

2. 4,+0. 2*

0.9+0.2**

1. 0+0. 2**

1. 6+0. 4**

10-6

2.5+0.3**

1. o+o. 2**

1. 3+0. 3**

'
2.3+0.7**
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'

10-5

60
39

a + Standard error of the mean.
b + Standard deviation.
c Film recording poor with this observation for accurate measurement, but no change in frequency
was apparent.

*
>!<>:<

Diff e!'ence statistically significant at 1% level.
Difference statistically si.gnificant at O. l % level.
M. e. . n. s too small to me::i.sure accuratel .

TABLE 2B
Effects of Neostigmine on E. p. p. s. (2 ug/ml Tc)

Concentration
of
neostigmine (M)

Membrane
potential
(mV)

Rise-time
(msec)b

Half-decay
(msec)0

5.4+0.2

0.6+0.l

o. 9+0. 1

68

10- 8

6.9+0.3**

o. 6+0. 1

0.9+0.l

68

10- 7

8.5+0.3**

o. 8+0 . .1*

1. 3+0. l**

68

Control

10-6

Ampli~de

(mV)

Muscle began
to twitch

a + Standard error of the mean.
b
Standard deviation.
c Jfilm recording poor with this observation for accurate measurement, but no change in frequency
was apparent.
>:< Difference statistically significant at 1% level.
0
•: :c
Difference statistically significant at 0. 1% level.
--- M. e. p. p. s too small to measure accurately.

+

08

Effects of neostigmine on (+)-tubocurarine e. p. p. s.
At 10- 8 M neostigmine, a very significant increase in amplitude was
produced with no change in-time course:

-~he

amplitude and time course

both increased at 10~ 7 M neostigmine; however, the increase in amplitude·
was greater (57%) than the increase in rise-:-time (33%) or half-decay
(44%).

6
At l0- M neostigmine the muscle began to twitch and the record-

ings were lost.

Table 2B illustrates the effects of neostign1ine on single

e.p.p.s.

~ffects

of edropJ:i_?.nium on m. e. p. p. s

In four experiments infusion of concentrations of edrophonium of
10- 8M or greater produced a very significant increase in m. e. p. p. fre-

quency (Figure 1).

This effeCt was reversed after the muscle had been

-returned to Krebs solution for 60 min. (Table 3A).

There were no significant changes in amplitude or time course of the
m. e. p. p. s. with edrophonium concentl·ations up to 10- 5 M.
e. p. .

At 10- 4M the

membrane potential was depolarized to 4lm V and the m. e. p. p. s.

were no longer visible.

The control readings were again obtained 60

min after the infusion of drug solution had been replaced by Krebs solution.
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Figure 1. The effect of edrophoniµm on m. e. p. p. frequency. (a) Control
(b) In the presence of edrophonium 10- 8M. Voltage calibration, 1 m V;
time calibration, 0. 2 sec.

·,

..--------------------------------------------------..-..·\----....
I

'

TABLE 3A
Effects of Edrophonium on M. e. p. p. s

Frequency
of
m. e.
s
(sec- )a

Amplitude
(mV)b

Rise-time
{msec)b

Half-decay
(msec)b

1. 7+0. 1

0.6+0.2

1. l+O. 2

1. 4+0. 3

70

10-8

2.7+0.4**

o. 6+0.1

1. 2+0. 2

1. 3+0. 3

70

10-7

2.8+0.5**

o. 6+0.1

1. o+o. 2

1. 5+0. 3

71

2. 5+0. 2**

0.7+0.2

1. 3+0. 2

1. 5+0. 3

70

2.5+0.2**

0.6+0.2

1. 2+0. 1

1. 5+0. 2
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Concentration
of
edrophonium {M)
Control

10

-6

10- 5
10-4

For symbols see Table 2A.

P·R·

i

Membrane
potential
(mV)

48

.--------------------------------------------~\----c,
.\ I,.
TABLE 3B
Effects of Edrophonium on E. p. p. s (4 µg/ml Tc)

Concentration
of
edrophonium (M)

Membrane
potential
(mV)

Amplitude
(mV)b

Rise-time
(msec)b

Half-decay
(msec)b

Control·

3.5+0.2

0.7+0.l

0.9+0.l

65

10-8

3.6+0.l

0.7+0.l

0.9+0.l

65

10-7

4.0+0.2**

0.7+0.l

1. 0+0, 1

65

10-6

5,5+0.2**

o. 8+0. 1

1. 2+0, l**

65

10-5

9,3+0,3**

1. 2+0. l**

2.4+0,l**

65

Muscle began to twitch

For symbols see Table 2A.
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Effects of edrophonium on (+)-tubocurarine e. p. p. s.
In three experiments 10-SM edrophonium produced no significant
changes in the amplitude or time course of the e. p. p. s; l0- 7M increased
the amplifude with no-·changein time cour::re~--ct(J'"- 6 M and10-= 5 M increased
both amplitude and time course.

At 10-GM the increases were:amplitude

57%, rise-time 14%, half-decay 33%, and at 10- 5M, amplitud~ 165%,
rise-time 71% ancl half-decay 167%.

Ten minutes after perfusion with

10- 5M edrophonium, the muscle began to twitch and the recording was
lost (Table 3B).

Effects of ambenonium on m. e. p. p. s
In four experiments ambenonium did not produce any significant
increase in m. e. p. p. frequency.
4A, the frequency decreased at 10

at 10-7M.

In the experiment illustrated by Table
-9

M and 10

-8

M but there was no change

The amplitude and time course were very significantly increased

at concentrations of 10-6M and 10- 7 M

At l0- 7M the amplitude was

increased by 71%, the rise-time 57%, and the half-decay 1 70%.
decay decreased at 10
ambenonium.

-6

M and the m. e. p. p. s disappeared in 10

The half-5

M

The m. e. p. p. s returned when the drug solution was replaced

by Krebs solution at the increased amplitude and time course which did not
return to control values after three hours perfusion.

~~--=_....._,.,,__,._

___..,,....._.,....__...,__

_.._.._.~-=-•nm,___.......,

_____,,_______....,._,..____,_.,
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L

P."'igure 2. The effect of ambenonium on e. p. p. and m. e. p. p. amplitude and
time course. (a) .E. p. p. s. recorded in the presence of 5 µg/ml tubocurarine; A--control; B-- with 10- 9 M ambenonh:_rf; C--with 10- 8 M ambenonium. (b) M. e. p. p. s.: A--control; B--with 10 M ambenonium. The thick
base line is due to the record being photographed from a recurrent sweep,
the camera shutter being left open until a m. e. p. p. occurred. Voltage
calibration, (a) 5 m V, (b) O. 5 m V; time calibration, (a) I msec. {b) 1 msec.

--·

TABLE 4A
Effects of Ambenonium on M. e. p. p. s

Frequency
of
m. e. p. p. s
(sec-l)a

Amplitude
(mV)b

Rise-time
(msec)b

Half-dec~y
(msec)b

Control

1. 5+0. 1

0.7+0.l

o. 7+0.1

1. O+O. 3

66

10-10

1. 3+0. 3

0.7+0.l

0.7+0.l

1. l+O. 2

65

10-9

1. l+O. 3**

0.7+0.l

o. 7+0. 1

1. o+o. 2

61

10-8

1. 2+0. l**

0.8+0.2

o. 8+0.1

1. 3+0. 3

58

10-7

1. 5+0. 2

1. 2+0. l**

1.1+0. 2**

2.7+0.4**

56

10- 6

1. 3+0. 2*

1. 2+0. l**

1. l+O. 2**

2.3+0.6**

60

Concentration
of
ambenonium (M)

10- 5

Note: Changes in m. e. p. p. frequency show a statistically significant decrease.
For symbols see Table 2A.

Membrane
potential
(mV)

65

1

TABLE 4B

Effects of Ambenonium on E. p. p. s. (5 µg/ml Tc)

Concentration
of
ambenonium (M)

Membrane
potential
(mV)

Amplitude
(mV)b

Rise-time
(msec)b

Half-deca:b
(msec)

5.8+0.3

0.7+0.l

1. O+O. 1

10-10

6.3+0.2**

0.7+0.l

1. o+o. 1

78

10-9

6.5+0.3**

0.7+0.l

1. o+o. 1

78

10-8

13. 8+0. 7**

1. l+O. l**

1. 8+0. l**

80

Control

10-7

For symbols see Table 2A ·

Muscle began to twitch
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When using ambenonium, it was difficult to maintain a stable endplate membrane resting potential throughout a complete experiment due to
the muscle twitching at concentrations between 10- 9 M and 10-7M.

The

shift in membrane potential in the experiment illustrated in Tab le 4A was
not due to depolarization but due to movements of the electrode caused
by the muscle twitching.

In some experiments it was possible to observe

a stable resting potential up to a concentration of 10- 8M.

In these experi-

ments there was no change in amplitude or time course of the m. e. p. p. s
with 10- 10 M or 10-9M.

However, there were significant changes in

amplitude, rise-time and half-decay at 10-8M and, therefore, the change
in membrane potential shown in Table 4A did mask changes occurring
with 10- 8M ambenonium.

Effects of ambenonium on (+)-tubocurarine e. p. p. s

In three experiments 10-lOM and 10-9M ambenonium produced a very
significant increase in e. p. p. amplitude with no change in time· course
(Figure 2).

At 10- 8M the amplitude was increased by 138%, the rise-time

by57% and the half-decay by 80%.

At 10

-7

and no further recordings were possible.

M the muscle began to twitch
(Table 4B).
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Effects of methoxyambenonium on m. e. p. p. s

'

In three experiments methoxyambenonium produced a significant
jrtcrease in m. e. p. p. -frequency at-10-:~M.---No-significant increase in
amplitude or rise-time was observed.

The half-decay increased at 10- 7 M ·

and 10-BM. At 10-5M them. e. p. p. s. disappeared with no change in end:plate membrane potential.

The drug solut"ion was replaced by Krebs

solution and them. e. p. p. s. returned at an increased amplitude and time
course which did not completely return to control values after 150 min.

In

one experiment the m. e. p. p. frequency was greatly increased in the
final rinse solution.

(Table 5A).

Effects of methoxyambenonium on (+)-tubocurarine e. p. p. s
Methoxyambenonium, at a concentration of 10- 8 M, increased the
amplitude of the e. p. p. s without change of time course.

At 10- 7 M and

10- 6 M both amplitude and time course were increased; 10-6M increased
the amplitude by 219%, the rise-time by 114% and the half-decay by 211%.
After 15-min perfusion with 10- 6M methoxyambenonium, the muscle began
to twitch and the recording was lost.

(Table 5B).

Effects of acetylcholine

In four experiments acetylcholine (ACh) produced no consistent

TABLE 5A
Effects of Methoxyambenonum on _M. e. p. p. s.

!

Frequency
of
m. e.
s
(sec- )a

Amplitude
(mV)b

Rise-ti~e

2. l+O. 3

0.7+0.l

0.6+0.l

1. o+o. 2

73

10-8

2.7+0.4*

0.6+0.l

o. 5+0. 1

1. o+o. 2

73

10-7

2. l+O. 4

o. 8+0. 1

0.7+0.l

1. 5+0. 2**

71

10-6

2.0+0.2

o. 6+0,l

0.7+0.l

1. 5+0.1**

73

Concentration
of
methoxyambenonium (M)
Control

10-5

For symbols see Table 2A.

P·f·

I

I

(msec)

Half-deck.y
(msec)b

Membrane
potential
(mV)

71

i

TABLE 5B
'

I

Effects of Methoxyamenonium on E. p. p. s. (3µg/ml Td)

Concentration
of
methoxyambenonium (M)

I

Membrane
potential
(mV).

Amplitude
(mV)b

Rise-time
'. (msec)b

Half-decay
(msec)b

3. l+O. 2

0.1+0.1

0.9+0.l

66

10- 8

3.6+0.2**

0.8+0.l

0.9+0.l

66

10-7

6.6+0.4**

1. o+o. l**

1. 3+0. l**

68

10-6

9.9+0.6**

1. 5+0. l**

2.8+0.l**

68

Control

For symbols see Table 2A

bO

changes in m. e. p. p. frequency, either as the concentration was increased
during the sarv.e experiment or at the same concentration in different
experiments.

The frequency varied throughout the experiment and it is

unlikely that any changes were drug-induced.

ACh did not increase the

amplitude or time course of the m. e. p. p. s, but at concentrations greater
than I0- 4 M, the amplitude diminished as the end-plate membrane was
depolarized.

(Table 6).

Effects of tubocurarine
Experiments using tubocurarine alone showed no significant changes
of amplitude ur time course of e. p. p. s over a period of 2 hr. In
experiments using 5-10 µg/ml tubocurarine, similar changes tO those
recorded above were observed but higher concentrations of the facilitatory
drugs were required.

Concentrations of tubocurarine of 10-15 µg/ml

completely prevented any increases in amplitude and time course in the
presence of the facilitatory drugs.
DISCUSSION

.All the facilitatory drugs used produced statistically significant
changes in m. e. p. p. frequency.

However, the changes were small and

assuming that a ten fold increase in frequency of the m. e. p. p. s repre-

TABLE 6
Effects of Acetylcholine on M. e. p. p. s

Frequency
of
m. e. p. p. s
(sec-l)a

Amplitude
. (mV)b

Rise-t~e

(msec)

Half-decw
(msec)

1. 2+0. 2

0.8+0.2

0.6+0.l

1. o+o. 2

70

10-8

1. l+O. 1

0.9+0.2

o. 7+0. 1

I. o+o. 2

71

10-7

1. 3+0. 4

0.9+0.2

o. 7+0.1

0.9+0.2

70

10-6

1. 5+0. 3*

0.8+0.2

o. 6+0. 1

1. o+o. 2

71

10-5

1. 5+0. l**

o. 8+0. 1

0.6+0.2

1. l+O. 1

71

10-4

1. 5+0. 2**

0.7+0.l

o. 6+0.1

1. o+o. 2

70

Cone entration
of
acetylcholine (M)
Control

10-3

For symbols see Table 2A.

Membrane
potential
(mV)

49
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sented a 15 mV depolarization of the nerve terminal (Liley, 1956b),
depolarization of the terminal could only have been in the order of 1 to 3
m V.

Also, m. e. p. p. frequency varies over an extended period of time

(Boyd and Martin, 1956a) thus some of the changes noted may have been
spontaneous and not drug-induced.

Boyd and Martin (19 56a) also. noted a change in m. e. p. p. frequency
using 3. 3 X 10- 7 M neostigmine and a decrease at 3. 3 X 10- 6 M, but as in
the present results, the changes recorded were only small.

The reduction

of frequency at higher concentrations may simply reflect the difficulty
in observing the m. e. p. p. s which were greatly decreased in amplitude
when the end-plate was depolarized.

No change in m. e". p. p. frequency

has been observed in the frog sartorius using neostigmine (Fatt and Katz,
1952) or iri the rat diaphragm using neostigmine (Liley, 1956a).

It is difficult to assess the importance of the small changes in nerve

terminal membrane potential that these increases in m. e. p. p. frequency
reflect.

The change in spontaneous release of ACh indicated by the

change in m. e. p. p. frequency is probably not physiologically significant.
However, this small e.ffect on the terminal may be indicative of a presynaptic action which do.es have significant effects on the release of A Ch
due to nerve action potentials.
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The changes in time course of them. e. p. p. s were much more easily
observed and more consistent than the changes in amplitude.

Since the

changes in a.~plitude were small_<:~?__o_n~y_()_':~ur:~:?_i1:_~~e p:r~s_ence of
changes of time course, it can be concluded that the drugs produced no
significant changes in the sensitivity of the end-plate.

This conclusion

confirms that of Blaber (1963), and the changes in end-plate sensitivity
produce.cl by methoxyambenonium in frog muscle (Karczmar et al., 1961)
point to a species difference in the effect of these drugs at the neuromuscular junction. A logarithmic plot of amplitude during the decay of the
e. p. p. was found to be linear with time, both in the control recordings
and in the presence of facilitatory drugs; thus an increase of the time to
half-decay indicates prolongation of time course.

The degree of prolon-

gation gives a rough estimate of the anticholinesterase activity of these
compounds.

Thus ambenonium is the most potent cholinesterase inhibitor,

while neostigmine, methoxyambenonium and edrophonium exhibit decreas - ;
ing potencies.

Edrophonium produces no effects on m. e. p. p. amplitude

or half-decay.

This indicates that edrophonium does not inhibit cholin-

esterase up to a concentration of 10

-6

M.

Changes in amplitude and time

course of m. e. p. p. s have been reported in other species previously,
neostigmine (3. 3 X 10- 6M) in frog sartorius (Fatt and Katz, 1952}, neo-
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6
stigmine (3. 3 X 10- M) in rat diaphragm (Liley l956a.) and also in the cat
tenuissimus muscle,, neostigminefa. 3 X 10- 7 M) (Boyd and Martin, l956a).
Edrophonium (lo- 4 M) and neostigmine (10- 5M) produced depolarization
of the end-plate,, confirming the conclusions of Nastuk and Alexander
{1954).. and Katz and Thesleff (1957).

These concentrations are higher

than those necessary to facilitate transmission and would indicate that
depolarization of the end-plate is not a factor in the production of
facilitation of neuromuscular transmission by these drugs .. confirming the
conclusion of Blaber and Bowman (1959).
5
Ambenonium (l0- M) and methoxyambenonium {lo- 5 M) produced a
decrease in the amplitude and time course of the m. e. p. p. s without
any change in the resting potential of the e. p. membrane.

These drugs

have been shown previously to produce neu1·omuscular paralysis
resembling that of {+)-tuobcurarine (Blaber, 1960).

This potent curare-

like action may account for the unusual observation that methoxyambenonium increased the half-decay time but not the amplitude of the m. e.
p. p. s.

The facilitatory drugs also increased and prolonged the {+)-tubocurarine e. p. p. but the effects on e. p. p. s occurred at concentrations which hac

I
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no effect on the m. e. p. p. s.

This fact, together with an increase in

amplitude and no change in time-course of the . e. p. p. indicates a presynaptic action .for these drugs.

Masland and Wigton (1940) and Eccles (1964) have suggested that
ACh may be mediating in the action of the facilitatory drugs on the motor
nerve terminal after inhibition of cholinesterase. However, the present
results show that the time course of the e. p. p. was not prolonged at the
time it was augmented, showing cholinesterase was not inhibited.

Also,

A Ch was found not to produce any change in frequency of m. e. p. p. s, thus
confirming the results of Hubbard, Schmidt and Yokota (1965).

These

results, although not eliminating ACh as a mediator, would suggest that
nerve terminal effects are not produced by a previous inhibition of
cholinesterase, though the drugs may sensitize the nerve terminal to an
action of ACh.

The action of ACh would not be to depolarize the terminal,

since no change in m. e. p. p. frequency was produced.

Because the amplitude of the m. e. p. p. s was not increased in the
absence of a prolonged time course, it can be assumed that the size of
the quantum is not increased by facilitatory drugs.
release for each stimulus

mu~t.

quantal content of the e. p. p.

The increase in ACh

therefore. be due to an increase in the

86

Further work is required to support the present conclusions since
they are based upon the assumption that m. e. p. p. s and e. p. p. s di.ffer
only in their mechanism of release.

But m. e. p. p. s are well kr10wn for

their small and highly variable amplitude (Fatt and Katz, 1952).
are comparatively large and very constant in amplitude.

E. p. p. s

It is possible

that the present results show no significant changes of the m·. e. p. p. s
only because of this high variability.

This can be illustrated by the

results with methoxyambenonium (Table 5). 10- 8M methoxyambenonium
increased the e. p. p. amplitude by 16%.

The same percentage increase

of the m. e. p. p. amplitude (O. 7 to O. 8mv) would not have been significant.
Thus the initial conclusion that the facilitatory drugs act by a pre-junctional action is weakened and must be tested by further experiments.
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RESULTS SECTION 2

EFFECTS OF FACILITATORY DRUGS ON
(+)-TUBOCURARINE E. P. P. SAND IONTOPHORETIC
ACETYLCHOLINE AND CARBACHOL POTENTIALS.
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INTRODUCTION

From the prev-ious experiments it was concluded that the e. p. p.
amplitude-was augmented at a concentration of facilitatory drug which was
approximately one-tenth the concentration necessary to produce an effect
on m. e. p. p. amplitude or time-course.

Since m. e. p. p. s have a high

variability and low amplitude, further experiments were performed to
provide additional information regarding the mechanism of action of the
facilitatory drugs.

Therefore experiments were performed with the

same drugs, using a microelectrode drug application technique (Nastuk,
1953a and Del Castillo and Katz, 1955a).
following reasons.

This technique was used for the

First, the membrane potential change resulting

from iontophoretic application of ACh is not as V8.riable as m. e. p. p. s.
Second, the ACh-potential can be adjusted to any desired amplitude, simply
by increasing the current which passes through the electrode.

Finally.

it is possible to record both the e. p. p. and ACh-potential at the same

muscle. e. p., thereby eliminating any variability of drug response which
may occur between different muscle fibers.

RESULTS

It proved to be quite difficult to maintain ACh-potentials at a
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constant amplitude for long periods of time.

Thus both ACh-potential

amplitude and half-decay time were observed to ·determine the presence
of drug-induced changes to the response of ACh at the e. p. membrane.
--

·-

---··

~--

-

(The half-decay seemed very constant·for long periods of time, even
though the amplitude decreased considerably.)

Effects of the facilitatory drugs on (+)-tubocurarine e. p. p. s and A Chpotentials.
Neostigmine.

Table 7 shows the results obtained from two experiments with
neostigmine.

In EXP #1 neostigmine produced no

signi~icant

changes at

10- 8M, although there were ·small effects {less than 10%) on the AChpotential.

At 10- 7 M there were large changes in both the e.p.p. and

A Ch-potential.

mine.

In EXP #2 the e. p. p. was augmented by 10-8M neostig-

The increase was 28% of control and was highly significant.

Also,

the ACh-potential was prolonged by 17%, although this increase was not
as significant as the effect on the e. p. p .

.E_~drophonium.

It was quite difficult to produce the e. p. p. changes at 10- 7 M edrophonium which had been observed in the prmous section.

However,
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TABLE 7
Effects of Neostigmine on E. p. p. s
,

· Concentration
of
neostigmine (M)

.. and ACh-potentials (4 µg/ml. Tc)

·-·E. P. P.

amplitude
(mV)b

. --Ach -potential
amplitude
(mV)b

A Ch-potential
halfideca:b
{msec)

EXP #1

2.6+0.2

1. 4+0. 1

480+30

2.5+0.1
(0)

1. 5+0. 2
(7%)

520+30
-(8%)

3.6+0.2**
(38%)

3.3+0.2**
(i::j6%)

760+50*ii~

Control

1. 8+0. 1

I. 3+0. 1

120+10

I0- 8 M

2. 3+0. Iii~*
(28%)

I. 3+0. 1
(0)

140+10*
0.7%)

Control
10- 8 M

10

-7

M

(58%)

EXP #2

~~

Difference statistically significant at the 1% level.

** Difference statistically significant at the 0.1% level.

b

+ Standard deviation.
Values in parentheses indicate the percentage increa.se over control.
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TABLE·a
Effects of Edrophonium on E. p. p. s
.

and ACh-potentials (4 µg/mlTc}

E. P. P.
amplitu.ge
(mV) .

A Ch-potential
amplitude
{mV)b

ACh-potential
half-decay
{msec)b

Control

I. o+o. 1

I. 9+0. I

110+10

I0- 7 M

1. l+O. 1

1. 5+0. I

110+10
(0)

Concentration
of
edrophonium (M)
EXP #1

(10%)

- (0)

EXP #2
Control

1. 4+0. 1

1. 8+0. 3

280+10

10- 6M

2.2+0.2**
(57%)

2. 1+0. 2
(17o/o)

350+20**
(25%)

Control

1. 5+0. 2

1. 7+0. I

550+30

10-BM

1. 4+0. 2

I. 4+0. I

500+60

EXP #3

(O)

I0-7M

1. 5+0. 2
(O)

10- 6M

2. o+o .. 2~~*
(33%)

(0)

(O)

1. 8+0. 1

620+60
(20%)

(6%)
2. 7+0. 2::.;;*
(59%)

710+40>:•*
(29%)

For symbols see Table 7

L-..------------------------...---...----------------------------..---~~"'""""'--d
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there were large changes in both the e. p. p. and ACh-potential at 10- 6 M
edrophonium (Table 8).

· Ambenonimn.
The experiments with ambenonium resulted in almost identical
increases in e. p. p. amplitude and ACh-potential half-decay (Table 8 and
Figure 3).

The only difference occurs in EXP #2 at

io- 9 M

ambenonium

when the e. p. p. was augmented, significantly, by 16% while the AChpotential half-decay was increased by 8%. which was insignificant.

Methoxyarnbenonium.
EXP #1 shows large increases in e. p. p. amplitude and ACh-potential
8
amplitude at 10- M methoxyambenonium.

10- 8 M was much less effective

in EXP #2, although the small increase of e. p. p. amplitude was sign: f'icant (Table 10).

Time-course of anti-Tc action.
In a series of four experiments effects of the facilitatory drugs were
observed continuously from the beginning of drug infusion.

In this way it

was possible to determine if effects on e. p. p. amplitude followed the
same time-course as effects on ACh-potential amplitude or half-decay .
.The results of one experiment are illustrated in Figure 4,

Records were
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A

-

-

Figure 3. The effect of ambenonium on e. p. p. s and ACh-potentials
recorded in the presence of 4 µg/ml (+)-tubocurarine:A- -control e. p. p.
and ACh-potential; B-~with 10-8M ambenonium. Voltage calibration, 5mV;
time calibration, 100 msec; current, 2. 5 x 10- 7 amps.
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TABLE 9
Effects of Ambenonium on E. p. p. s

•

e oncentration
of
ambenonium (M)

and ACh-potentials (4 µg/ml Tc)

--E. P. P.
amplitude
(mV)b

ACh-potential
ampli~de

(mV)

ACh-potential
half-decay:
(msec)b

EXP#l
Control

1. 7+0. 1

2. ·4+0. 2

80+10

10- 9M

1. 7+0. 1

1. 4+0.1

90+10
(13%)

10

-8

M

-(0)

(O)

3.0+0.2**
(76%)

2.8+0.3
(17%)

l40+10:\0 l:

1. 9+0. 1

2.0+0.2

130+10

2. 2+0. l*:\(
06%)

I. 9+0. 1
(O)

140+10
(8%)

5. l+O. 5*:\(
(l68%)

2.2+0.1
00%)

350+10:\(:\C
(169%)

(75%)

EXP #2
Control
l0- 9 M
10- 8 M

For symbols see Table 7
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TABLE 10
Effects of Methoxyambenonium on E. p. p. s

,
Concentration of
methoxyambenonium (M)

and .AC:h-potentials (4 µg/ml Tc)

E. P. P.
amplitude
(mV)b

AGh-potential
amplitude
(mV )b

AGh-potential
half-decal
(msec)

Control

6.6+0.3

4. 2+0. 1

60+10

10-BM

11. 4+0. 2*:>i'<
(73%)

6.6+0.8**
(57%)

50+10
(0)

Control

2. 1-10. 1

I. 7+0. 1

140+10

10-BM

2. 4-IO. J>:c
(14%)

I. 5+0. 1
(0)

150+10

3. 8+0. 3*>:c
(81%)

I. 2+0. I

180+10**
(29%)

EXP #1

EXP #2

10- 7 M

For syi.nbols see Table 7

(O)

(7%)
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Figure 4. The effect of ambenonium on e. p. p. (•) and ACh-potential (x).
amplitude recorded in the presence of 4 µg/ml (+)-tubocurarine versus time:
A --beginning of 10- 8 M ambenonium infusion; A2-- beginning of rn- 7 M
1
ambenonium infusion.
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made every thirty seconds throughout the experiment.
relatively constant.

10-SM ambenonium produced parallel increases in

both e. p. p. amplitude and ACh-potential amplitude.
-beginning-to -infuse 10

The controls were

-7

Two minutes after

M ambenonium,- both-potentials.increased very

rapidly in amplitude.
Effects of the facilitatory drugs on (+)-tubocurarine e. p. p. s and
carbachol-potentials.
Non~ of the drugs studied (neostigmine, edrophonium, ambenonium

and methoxyambenonium) produced changes in the carbachol-potential at
doses which caused considerable augmentation of e. p. p. amplitude.
is illustrated in Figure 5.

This

After control records, l0- 6IVJ methoxy·-

ambenonium was administered.

The e. p. p. and carbachol-potential were

recorded every thirty seconds.

After three minutes of methoxyambenonium

infusion there was a rapid augmentation of the e. p. p. amplitude, but no
change in the carbachol-potential.

After four minutes, the e. p. p. was not

recorded to avoid any subsequent muscle twitches.

Even after ten

minutes there was no change in the carbachol-potential.
DISCUSSION

In five of seven experiments there was a statistically significant

\'
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A

-l

B .

J.._
..-

L

Figure 5. The effect of methoxyambenonium on e. p. p. s and carbacholpotentials recorded in the presence of 4 µg/ml (+)-tubocurarine: A--control
e. p. p. and carbachol-potential; B--with 10- 6 M methoxyambenonium.
_
8
Voltage calib.1;~~tion, 5 m V; time calibration, 500 msec; current, 3. 2xl0
amps.
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increase in ACh-potential amplitude or half-decay at the same minimal
concentration as the increase in e. p. p. amplitude.

Two experiments in

which there was no correlation (ambenonium EXP #2 and methoxyambenonium EXP #2) showed small, but significant, increases in the e. p. p. amplitude at concentrations which did not significantly affect the ACh-potential.
Yet the changes of the A ch-potential are 50% as large as the changes in
the e. p. p. at the low concentrations.
10

-8

In fact, in ambenonium EXP #2

M ambenonium produced exactly the same percentage changes (168%

and 169%) in e. p. p. amplitude and ACh-potential half-decay.

On the

basis of these results it seems likely that there is a good correlation
between the effects of facilitatory drugs on the e. p. p. and ACh-potential
in a curarized mammalian neuromuscular preparation.

This conclusion is substantiated even further by the observation that
augmentation of the e. p. p. and ACh-potential amplitudes follow approximately the same time course, as shown in Figure 4.

These conclusions

are very similar to those of Goldsmith (1963) and Otsuka and Nonomura
(1963).

Both papers gave results showing the effects of edrophonium on

e. p. p. s and ACh-potentials at the frog neuromuscular junction.

Correlation between effects of facilit:i.tory drugs on e. p. p. s and
A Ch-potentials can be explained by several postsynaptic mechanisms of
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action.

The most likely mechanism involves the cholinesterase inhibiting

properties of the facilitatory drugs.

This theory receives strong support

from the observation that the action of a stable choline ester (carbachol)
is not affected by facilitatory drugs.

This would eliminate the other

possibilities, sensitizing and depolarizing actions, which have been
hypothesized (Riker and Wescoe, 1946 and Karczmar, 1957). · If sensitizing
or depolarizing actions were occurring, an increase in the carbacholpotential should have been observed.
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RESULTS SECTION 3

EFFECTS OF FACILITATORY DRUGS ON
QUANTAL CONTENT OF THEE. P. P.

102

INTRODUCTION

Calcium ions are essential for transmitter release at the neuromuscular junction. By decreasing the calcium ion concentration or
increasing the magnesium ion concentration in the Ringer solution,
release of transmitter can be decreased to any level.

At appropriate

concentrations of calcium and magnesium the average quanta in a single
e. p. p. is near one {equivalent to a m. e. p. p. ).

At this level of blockade

it is possible to quantify transmitter release per indirect stimulus (Del
Castillo and Katz. 1954c). ·

The facilitatory drugs were tested in a deficient calcium preparation
to determine if they were capable of increasing the quanta! content of
the e. p. p ..
RESULTS

The effects of neostigmine. edrophonium, ambenonium and methoxyambenonium are illustrated in Tables 11 to 14, respectively.

The quanta!

content was measured by two methods:

and

I)

ave. e. p. p. amplitude of 50 samples
ave. m. e. p. p. amplitude of 50 samples

2)

loge no. of e. p. p. s
no. of failures

in 200 trials (Figure 6).
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Figure 6. Effect of edrophonium on quanta! release. Indirect stimulation
at the artifact. (a) control; (b) with I0- 6M edrophonium. Voltage calibration, 1 m V; time calibration, 5 msec.
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TABLE 11

Effect of Neostigmine on Quanta! Content

Quanta! Content
Concentration
of
neostigmine (M)

Mg (10-15mM)a
Muscle 1

Muscle 2

Ca (O. 92 mM)
Mg (5-? mM)b
Muscle 3
Muscle 4

2.1

1. 9

0.54

o. 71

2.1

2. 0

0.42

0.87

10- 7

2.1

1. 9

0.68

0.70

io- 6

1. 7

0.64

0.73

10- 5

. 1. 8

Control
10

-8

o. 82*

Average amplitude of 50 e. p. p. s
a - Average amplitude of 50 m. e. p. p. s
b

*

_

number of stimuli
Log en·1mber of failures

indicates a significant increase of 33% or a significant decrease of
25% (Edwards and Ikeda, 1962).
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TABLE 12

Effect of Edrophonium on Quantal Content

Quantal
Concentration
of
edrophonium (M)

Mg{l0-15 mM)a
Muscle 1

Muscle 2

Conte~_!

Ca (O. 92 mMb
Mg (5-7 mM)
Muscle 3
Muscle 4

Control

1. 2

2.4

0.36

o. 87

10- 8

I. 2

2. 5

0.45

0.96

1. 2

2. 9

0.34

0.90

1. 6*

2. 6

0.44

1. 4*

10

-7

10-6
10- 5

For symbols see Table 11

2. 4

1. 3*
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TABLE 13

Effect of Ambenonium on Quanta! Content

Quanta! Content
Concentration
of
ambenonium (M)

Mg (10-15 mM)a
Muscle 1

Muscle

2

Ca (0. 92 mM)
Mg (5-7 · mM)b
Muscle 3
Muscle 4

Control

1. 6

1. 5

0.67

1. 9

10-10

1. 8

1. 6

o. 81

1. 8

10-9

1. 8

1. 7

0.66

1. 9

10-8

1. 8

2. o*

0.53

1. 7

10-7

2.0

2.2*

0. 33::!c

2. 0

10-6

1. 8

1. 4

o.2s*

1. 7

~

""'-5

10

1. 5

For symbols see Table 11

',
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TABLE 14
Effect of Methoxyambenonium on Quanta! Content

Quanta! Content
Concentration
of methoxyambenonium (M)

Mg (10-15 mM)

a

Ca (O. 92 mMb
Mg (5-7 mM)
Muscle 3
Muscle 4

Muscle 1

Muscle 2

2. 5

3. 6

0.79

1. 04

2. 5

3. 6

o. 89

o. 83

10-7

3.4*

3. 9

0.59

0.74*

10-6

3. 2

0.92

o. 82

Control
10

-8

For symbols see Table 11
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With either of these techniques the facilitatory drugs did not produce
consistent coonges in the quantal content of the e. p. p. at any concentration.

DISCUSSION

The quantal content of the e. p. p. in deficient calcium or increased
magnesium ions is not increased significantly by facilitatory drugs.
This is similar to the conclusion of Hubbard. Schmidt and Yokota (1965).
except they observed a small decrease in quantal content of the e. p. p.
in the presence of neostigmine.

M. e. p. p. s and e. p. p. s in high magnesium or low calcium are
augmented at.the same concentrations.

Also. both are depressed at

high concentrations. indicating the e. p. p. s and m. e. p. p. s are affected
by the same postsynaptic mechanisms.

Augmentation of the e. p. p. s and m. e. p. p. s is compatible with the
theory of cholinesterase inhibition by facilitatory drugs.

Depression at

higher concentrations is probably due to direct competitive or depolarizing .
actions. ·

Thus these results can be explained completely on the basis of
postsynaptic actions and they indicate that in a calcium deficient solution

.'
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facilitatory drugs do not increase release of transmitter from presynaptic nerve terminals.
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RESULTS SECTION 4

EFFECTS OF BENZOQUINONIUM
AT THE NEUROMUSCULAR JUNCTION

111

INTRODUCTION

Benzoquinonium {Bz} produces competitive blockade of neuromuscular
-transmission,,-and in this respect acts much like-(+)-tubocurarine.

The

distinguishing feature of benzoquinonium blockade is that it is not _antagonized by facilitatory drugs (Hoppe,, 1950; . Hougs and Johansen,, 1957;
Bowman,, 1958 and Blaber and Bowman,, 1962}. As Blaber and Bowman
(1963a and 1963b} concluded facilitatory drugs act at the motor nerve
terminal, Blaber and Bowman {1962 and 1963a} further concluded that
benzoquinonium prevents the action of facilitatory drugs at the motor
nerve terminal.

Alternatively,, it is possible that the potent anticholinesterase activity
of benzoquinonium (Hoppe, 1951 and Blaber and Bowman,, 1962) prevents
any subsequent inhibition of cholinesterase by facilitatory drugs.

The following experiments attempt to elucidate the sites of action
of benzoquinonium and thereby obtain presumptive evidence for the
mechanism of action of facilitatory drugs.
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CH2-CH3

CH 3- CH2- ~ - CH2- CH2-CH 2-NHI

CH2

0 .

0

CH2-CH3

-NH- CH 2- CH2- CH 2- ~ - CH 2- CH 3
.

0

BENZOQUINONIUM

I

CH2

~
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RESULTS

Benzoquinonium control
- The e. p. p. recorded when the

m~scle

was blocked by Bz progres- ·

sively decreased in size as a function of time.

This was especially evident·

in the amplitude, which decreased by approximately 50% after one hour
recording (Figure 7).

~f

There were much s'maller decreases in rise-time

and half-decay (Figure8).

Effects of the facilitatory drugs on the benzoquinonium e. p. p.
Infusion of concentrations of neostigmine, edrophonium, ambenonium,
or methoxyambenonium which increased the amplitude and/ or time course
of e. p. p. s recorded during Tc blockade, produced little change in the
rise-time, half-decay, or amplitude of the Bz e. p. p. (Figure 9).

There

was a continuous decrease of the amplitude; but the rate of decline resem-1;
bled closely that observed in the control e. p. p. with Bz alone.

Since the

drug concentrations were changed at 15 minute intervals, the slopes of
Figure 7 and 9 can be compared.

At high concentrations of the facili-

tatory drugs, effects on the e. p. p. were observed.

Concentrations

of 10- 4 M edrophonium caused a facilitation of all parameters.
neostigmine increased the time to half-decay.

10- 5M

Ambenonium prolonged the

.
-7
-6
half-decay at concentrations of 10 M and 10 M.

Also, 10

-5

M amben-
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Figure 7. E. p. p. amplitude recorded in a muscle fiber blocked by Bz
(2 µg/ml). Zero time represents the time at which an e. p. p. was located
and the first record taken.

.:-
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L

Figure 8. End-plate potentials recorded in a muscle fiber blocked by Bz
(1. 5 pg/ml). E. p. p. s recorded at 30 mins (upper trace}, 60 mins {center
trace, 90 mins (lower trace) after beginning of the Bz infusion have been
superimposed. Voltage calibration 5 m V; time calibration 1 msec.
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Figure 9. The effects of facilitatory drugs on the amplitude of e. p. p. s
recorded in a muscle blocked by Bz. C represents the control reading with
Bz alone. The facilitatory drugs were added 15 min after the control
reading and the concentrations increased at 15 min intervals.

onium and methoxyambenonium depressed the amplitude and rise-time.

Comparison of the benzoquinonium e. p. p. with the (+)-tubocurarine e. p. p.

It was observed that the values for the rise-time and half-decay of the_
Bz e. p. p. were prolonged when compared to a Tc e. p. p. In three experiments a muscle was initially blocked. with the lowest possible concentration
of Tc. ,After a rapid e. p. p. was found (rise-time
decay< 1. 5 msec),
became visible.

<

1 msec and half-

the Tc was removed by washing until the m. e. p. p. s

Then the $ame end-plate was blocked with Bz.

This

gave the results in Figure 10. When e. p. p. s of the same amplitude were
compared for any effect on time course, it was found that the rise-time
and half-decay of the e. p. p. s in Bz were about twice the duration when
compared to the rise-time and half-decay of the e. p. p. s in Tc.

When the

Bz was washed out and replaced by Tc, the time course returned to that
of the Tc control level.

Each change-over from Tc to Bz, or from Bz to

Tc, took approximately one hour. If a facilitatory drug was added to
Ringer solution of the final Tc e. p. p., the facilitating action of these
agents was considerably less potent than in the control Tc e. p. p.

This

decreased potency is obvious in the increased latency of action for
ambenonium.

Normally, 10- 7M ambenonium produced its anticurare

action in about five minutes,

but in the final Tc solution, the anticurare

~
~--c --------------~---------------------.
f~.:
~:;

,
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Bz
.
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Figure 10. Comparison of the time course of e. p. p. s recorded in a muscle
fiber blocked by Tc (2 µg/ml) and Bz (1. 5 µg/ml). Voltage calibration 5
m V; time calibration l msec.

..
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action of ambenonium was delayed to about 15 minutes.
·,

In addition, the

augmented amplitude of the e. p. p. occurred without any increase in the
rate of rise (~igure 11). An action of the facilitatory drugs increasing
the rate of rise of the e. p. p. during Tc blockade has been previously
reported (Kuperman and Okamoto, 1964).

Effect of benzoquinonium on m. e. p. p. frequency and time course
Bz had little effect on m. e. p. p. frequency.
8
increase which occurred at 10- M.

Concentrations of Bz up to 10
amplitude and time course.

-7

There was only a slight

There was no significant increase at

M produced no effect on the m. e. p. p.

At 10- 7 M Bz, the amplitude of m. e. p. p. s

was depressed without any change in the resting membrane potential, thus
confirming that Bz does not produce any depolarization of the end-plate.
At 10- 61\II the m. e. p. p. s were too small to measure accurately.

These

effects are illustrated in Table 15A.

Effect of benzoquinonium on Tc e. p. p. s

In three of four experiments Bz produced a facilitation of the Tc
e. p. p.
Bz.

7
As shown in Table 15B, this effect occurred at 10- 8 M and 10- M

The response was very slow to develop and the level of facilitation
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Figure 11. Comparison of the effects of facilitatory drugs in a muscle fiber
blocked by Tc before Bz (a) and after Bz(b). In a, A is a control e. p. p. recorded in a muscle blocked by 3 µg/ml Tc; B is an e. p. p. recorded when a
concentration of 10- 6 M edrophonium was added to the perfusion solution.
Between a and b the Tc was removed and the muscle blocked with Bz (1. 5
µg/ml). The Bz was then removed and the muscle re-infused with Tc. In b
A is a control e. p. p. recorded in a muscle blocked by 3 µg/ml Tc; B is an
e. p. p. recorded when a concentration of 10- 6M edrophonium was added to
the perfusion solution, and C when .I0- 5 M edrophonium was added to the per
fusibn solution. Voltage calibration 5 m V; time calibration 1 msec.
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TABLE 15A

..

Effects of B·enzoquinonium on M. e. p. p. s

Frequency
of
m. e. p. p. s
(sec-l)a

Amplitude
(mV)b

Rise-time
(msec)b

'
Half-de~y

3.0+0.4

1. 4+0. 3

o. 7+0. 1

1. 2+0. l

62

3.0+0.7

1. 5+0. l

o. 7+0. l

1. 3+0. 2

60

10-9

3. l+O. 3

1. 5+0. 3

o. 8+0. l

1. 3+0. 2

60

10- 8

3.7+0.5*

1. 4+0. 2

o. 7+0.1

1. 2+0. 1

60

10-7

3.3+0.6

0.9+0.2**

o. 7+0. 1

1. 2+0. l

60

Concentration
of
benzoquinonium (M)
Control
10

-10

(msec)

10- 6

60
i

'.

*
**

Differenc~ statistically significant at the 1% level.
Difference statistic.ally significant at the 0. 1% level.
--- M. e. p. p. s too small to measure accurately.
a
+ Standard error of the mean.
b
+ Standard deviation.

Membrane
potential
(mV)

'

. ...,.,

TABLE 15B
Effects of Benzoquinonium on E.-p. p. s
R.ecorded in the Presence of 4 µg/ml Tubocurarine

Concentration
of
benzoquinonium (M)

Membrane
potential
(mV)

Amplitude
(mV)b

Hise-time
(msec)b

Half-decay
(msec)b

Control

5. l+O. 4

0.7+0.l

1. 3+0. 1

73

10-10

5. l+O. 3

o. 8+0. 1

1, 4+0.1

75

10- 9

4.9+0.3

o. 8+0.l

1. 4+0. 1

77

10-8

5. 6+0. 4*

0.8+0.l

1. 3+0. 1

75

10- 7

7. o+o. 3>.'<*

o. 9+0. l**

1. 4+0. 1

75

10-6

Muscle began to twitch
i

For symbols see table 15A .

·-
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varies greatly between muscles.

At concentrations above 10

-7

M:,

the

three muscles in which facilitation occurred began to twitch; in the other,
the level of blockade was increased.

Bz, therefore, appeared to have a

weak facilitatory action which occurred at 10-SM and 10 - 7 M.

However,

7
Bz significantly depressed the amplitude of them. e. p. p. s at 10- M;
therefore, the weakness of the facHitatory action may have been due to
the presence of both facilitatory and curare-like actions at this concenc.·
tration.
Effect of benzoquinonium on quantal release
Bz, at concentrations which did not decrease the amplitude of the
m. e. p. p. s and e. p. p. s, produced no significant effect ori the quantal
release in the presence of a high magnesium ion concentration (12-15mM)
(50 m. e. p. p. amplitude/ 50 e. p. p. amplitude) or in low calcium (O. 92 mM)
and high magnesium (5-7 mM) concentrations, based on the number of
failures in 200 stimuli (Table 16). At concentrations where the m. e. p. p. s
and e. p. p. s were very small, due to the curare-like action of Bz, a just
significant reduction in the quantal content was observed.

~-----------------------------------------------------1-2_4_______

;.•

>.

TABLE 16

,
Effect of Benzoquinonium on Quanta! Content

Quanta! Content
Concentration
of benzoquinonium (M)

-Mg (10-15 mM)
Muscle 1

a

Muf?cle 2

Ca (0. 92 m~
Mg (5-7 mM)
Muscle 3
Muscle 4

o. 7

1. 2

10-10

o. 6

I. 4:

10-9

0.5*

1. 1

0.4*

1. 4

Control

10

-8

10-7

1. 6

2.3

1.4

2.5

1. 7

1. 9

0.7*

b

Average amplitude of 50 e. p. p. s
Average amplitude of 50 m. e. p. p. s
number of stimuli
Loge number of failures

*

Indicates a significant decrease (25% or more; Edwards and Ikeda, 1962).

a

~---------------------,

' .·r

125

;l

DISCUSSION
The potency of Bz in blocking neuromuscular transmission in the
isolated tenuissimus of the cat is approximately twice that of Tc, agreeing
· with the potency reported by Bowman il958) for ·the anterior tibialis
muscle of the cat in vivo.
The e. p. p. observed during Bz paralysis had a longer time course
than that observed during Tc paralysis; the rise-time and half-decay being
approximately double.

These effects can be explained on the basis of

cholinesterase inhibition by Bz.

At the concentration used to block the

muscle, 2. 4 - 4. 8 x 10- 6M, cholinesterase would be inhibited approximately
70-90% {Blaber and Bowman, 1962).

The e. p. p. in the presence of Bz

decreased in amplitude as a function of time.

The reason for this failure

to reach an equilibrium may have been due to a progressive decrease in
quantal content, however, the reduction in quantal content was only
observed at concentrations of Bz which reduced the amplitude of the e. p. p. s
and, therefore, the accuracy with which the number of failures could be
counted was also reduced.

Quantal release at the concentrations of Bz

used for blockade could not be measured by the techniques used.
Facilitatory drugs, at concentrations which increase the amplitude
of e. p. p. s in the presence of Tc produced no effect on the e. p. p. s in the
presence of Bz, thus confirming the lack of effect of facilitatory drugs
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in antagonizing Bz paralysis (Hoppe, 1950; Randall, 1951; Bowman, 1958;
Blaber and Bowman, 1962).
Ambenonium (10- 7 M) produced a prolongation of the time course of the
Bz e. p. p. thus showing the possibility of the further inhibition of cholin-esterase in the presence of Bz.

Bowman {1958) showed that TEPP would

produce a small amount of ·antagonism against Bz; ambenonium is also a
powerful cholinesterase inhibitor (Blaber, 1960) comparable in potency to
TEPP.

5
10- M ambenonium and methoxyambenonium produced depression

of the e. p. p., and high concentrations of these two drugs have been shown
to have a curare-like action (Blaber, 1960).
Neostigmine at 10- 5 M increased the time to half-decay, and slowed
the rate of decline in the amplitude of the Bz e. p. p. s.

Edrophonium at

4
a concentration of l0- M increased the amplitude and time course of the
Bz e. p. p.

At these concentrations edrophonium and neostigmine

depolarize the end-plate and also antagonize the bfocking action of Bz in
vivo in the cat (Blaber and Bowman, 1959).

The depolarizing action

produced at high concentrations of edrophonium and neostigmine is not
thought to contribute to the facilitatory a.ction (Nastuk and Alexander, 1954;
Katz and Thesleff, 1957a; Blaber, 1963).

Thus it must be concluded that the

facilitatory action of the drugs has ·been prevented by Bz.
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_Bz (lo-SM) increased the amplitude of the Tc e. p. p. without any
significant change in the time course, also there was no· effect on the
m. e. p. p. s at this concentration.

No increase in quanta! release has been

- shown for-Bz bythe-·techniques···used-in.--the ·p-resent study.

In this respect,

it resembles the facilitatory drugs used in this study which produced
similar effects.
e. p. p.

At 10-7M , Bz also prolongs the rise-time of the Tc

Higher concentrations of Bz produced only depression of the Tc.

e. p. p. due to its curare-like effect.

Bz has been previously shown to

antagonize the paralysis due to Tc in vivo in soleus and tibialis anterior
muscles (Hougs and Johansen, 1958).
Most of the effects of benzoquinonium can be explained on the basis
of its ability to inhibit junctional cholinesterase.

Thus benzoquinonium

inhibits cholinesterase as it produces competitive blockade of the muscle.
This cholinesterase inhibition accounts for the slight augmentation by
benzoquinonium of the (+)-tubocurarine e. p. p.

Also the facilitatory drugs

are not able to augment the benzoquinonium e. p. p. except at concentrations
which produce higher levels of cholinesterase inhibition (e.g. ambenonium)
or produce direct, depolarizing actions (e.g. edrophonium and neostigmine)
Although most of the evidence supports the theory of cholinesterase
inhibition, this theory is not supported by the experiment illustrated in
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Figure 11.

Edrophonium was not able to antagonize (+)-tubocurarine after

previous administration of benzoquinonium.
'.

This is similar to the

ability of (+)-tubocurarine to decrease a drug-induced prolongation of an
e. p. p. (Karczmar, Koketsu and Soeda, 1968).

This prolongation is

generally considered to be due to cholinesterase inhibition.

Yet it is

decreased by tubocurarine, even ·though tubocurarine has no· effect on
cholinesterase inhibition, in vitro (Eccles, Katz and Kuffler, 1942 and
Mcintyre and King, 1943).

This may be explained somewhat by the fact

that (+)-tubocurarine is capable of slightly decreasing the half-decay of a
normal e. p. p. (Beranek and Vyskocil, 1968).
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GENERAL DISCUSSION
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The experimental results indicate that facilitatory drugs have
several actions at the mammalian neuromuscular junction.

Some of these

results implicate a presynaptic mechanism of drug action for facilitatory
drugs.

The (+)-tubocurarine e. p. p. amplitude is augmented at a con-

centration which has no statistically significant effect on m. e. p. p. s.
is illustrated in Table 17.

This

E. p. p. amplitude is augmented at 1/10 the

concentration necessary to affect m. e. p. p. amplitude or time-course.
Furthermore drug-induced changes in m. e. p. p. s, when they occur, are
much smaller than drug-induced changes in e. p. p. s.

This differential

effect of facilitatory drugs on m. e·. p. p. s and e. p. p. s suggests that
facilitatory c:trugs have a presynaptic mechanism of action.

1'his con-

clusion is based on the assumption that m. e. p. p. s and e. p. p. s are
identical with exception that m. e. p. p. s do not require a nerv-e stimulus
for release.

This is not completely valid,

as there are several

limitations in the technique.
1) M. e. p. p. s and e. p. p. s were recorded in different experiments.

2) M. e. p. p. s were recorded in normal Ringers solution but e. p. p. s
were recorded in the presence of (+)-tubocurarine.
3) The amplitude of m. e. p. p. s averaged less than one m V while
e. p. p. s averaged more than three m V.
4) M. e. p. p. s involved one quantum of transmitter while e. p. p. s
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TABLE 17

,
;.,._

__ .

Minimal Molar Concentration of Drugs Producing
Significant Changes in M. e~ p. p. s and E. p. p. s

M. e. p. p.

Neostigmine

E~

Amplitude

Half-decay

Amplitude

Half-decay

10- 7

10- 7

10- 8

10- 7

10-7

10- 6

10- 8

10-10

10-8

10-7

10-8

10- 7

Edrophonium
Ambenonium
Methoxyambenonium

p. p.

10-8
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involved more than one-hundred quanta.
5) M. e. p. p. s were more variable in amplitude and time-course
than e. p. p. s.

These considerations, especially the greater variability of m. e. p. p. s,
make it questionable whether the effects summarized in TJ.ble 17 are
attributable to a presynaptic action of the facilitatory drugs.

It is possible

that these results are due to a general technical inability to detect small
changes in m. e. p. p. amplitude or time-course.

These complications are overcome by the method of iontophoretic
application of ACh to the

e~

p.

However, this method also has limitations.

1) Iontophoretic applications of ACh are not physiological.

They may

not be acting at the same receptors and do not exhibit the same
time-course of receptor activation as the normal release of ACh.
2) Prolonged application of ACh may affect neuromuscular transmission.
3) The A Ch-potentials are not always stable for the duration of an
experiment.

Facilitatory drugs produce much larger changes in ACh-potentials
than in m. e. p. p. s; thus the ACh-potentials seem more responsive tothe

&...-..--......----------------__,~------------------------------------------.....
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effeds of facilitatory drugs than the m. e. p. p. s.

At high drug concen-

trations there are no significant differences between the magnitude of

l
f~,.

augmentation of (+)-tubocurarine e. p. p. s and the magnitude of augmentation of ACh-potentials.

On the basis of this observation it would appear

that most of the changes of the e. p. p. which are induced by facilitatory
drugs can be explained on the basis of postsynaptic actions.

In order to

explain all the changes observed with facilitatory drugs on the basis of
postsynaptic actions it is necessary to show augmentation of the AChpotential and (+)-tubocurarine e. p. p. at the same minimal concentration of
facilitatory drug.

These results are summarized in Tuble 18.

There is

very good correlation between minimal concentrations 9f drug necessary
to augment (+)-tubocurarine· e. p. p. s and ACh-potentials.
discrepancy in the results of the iontophoretic studies.

There is a

The minimal drug

concentrations necessary to augment (+)-tubocurarine e. p. p. s in iontophoretic studies are consistently higher than minimal concentrations
necessary to augment (+)-tubocurarine e. p. p. s in m. e. p. p. -e. p. p.
studies.

At these higher concentrations facilitatory drugs are also

capable of prolonging m. e. p. p. s.

The only difference in experimental

technique is the presence of an ACh-electrode in the iontophoretic studies.
Thus this electrode must be depressing the effects of facilitatory drugs.
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TABLE 18

Minimal Molar Concentration of Drugs Producing
·- ·-·-Significant Changes in E. p~p. s and :A-Ch-Potentials

E. P. P.
Neostigmine

Edrophonium

ACH-POTENTIAL
-7
10

Exp #1·

10-7

Exp #' 2

10-8

10-8

Exp # 1

10- 6 ·

10-6

Exp # 1

10- 8

10- 8

Exp # 2

10

Exp # 1

10

-8

10- 8

Exp # 2

10-8

10-7

Exp # 2
Ambenonium

Methoxyamb enonium

-9

10

-8
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There are several possible explanations for this depressant effect.
1)

A depressant action of A Ch at the neuromuscular

junction~

ACh depolarizes the motor nerve terminal (Hubbard and Yokota,
1964 and Hubbard. Schmidt and Yokota, 1965), and this action

may depress the presynaptic actions of facilitatory drugs in
iontophoretic experiments.
2)

Damage to the nerve terminal.
Placement of an ACh-electrode involves considerable manipulation.

Such movement may damage the terminal such that it

does not respond normally to pharmacological tests.
· 3)

Use of low amplitude e. p. p. s.
Facilit~tory

drugs are relatively ineff eclive in augmenting low

amplitude e. p. p. s in the presence of high concentrations of
(+)-tubocurarine.

This is generally explained by a second action

of (+)-tubocurarine, but it is possible that the facilitatory drugs
are just not as effective in augmenting low amplitude e. p. p. s
as high amplitude e. p. p. s.

It is difficult to determine which of the above effects is responsible for a

lack of drug action in the iontophoretic experiments.

As the ACh-elec-

trocle had little effect on e. p. p. amplitude, it is unlikely that nerve termina
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damage can explain these results.

Any damage which would decrease the

pharmacological effectiveness of a drug should also decrease physiological
_rel.ease of transmitte~•.. Any_d.epola_:r:Jzatio11 ol_a._n_erve tt;?r:i:ninal b_y A Ch
would also be expected to decrease physiological release; although ACh
may depress actions of facilitatory drugs by another mechanism.

In spite of this discrepancy high concentrations of facilitatory drugs
are very effective in augmenting .or prolonging A Ch-potentials.

In fact

the ability of facilitatory drugs to affect ACh-potentials is nearly equivalent to their ability to affect e. p. p. s.

On the basis of this observation it

is necessary to conclude that most of the anti-Tc action of. facilitatory
drugs on isolated curarized mammalian muscle preparations is due to
postsynaptic actions.

To determine conclusively that there is not a small

presynaptic action by these drugs in the presence of (+)-tubocurarine, it
would be necessary to augment e. p. p. s and A Ch-potentials at lower concentrations in iontophoretic studies.

Low concentrations of a facilitatory drug produce an increase in the
rate of rise of (+)-tubocurarine e. p. p. s without prolongation of time to
half-dE'.cay.

This effect can be explained by increased release of trans-

mitter, sensitization of the e. p. to the transmitter or possibly, depolarization of the e. p. by facilitatory drugs (Otsuka and Endo, 1960b).

It is
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unlikely that facilitatory drugs have sensitizing or depolarizing actions,
as these drugs are not capable of augmenting carbachol-potentials.

This

appears to leave only a presynaptic mechanism.
~·

It is generally assumed that cholinesterase inhibition will augment and

~-

prolong the e. p. p. with no

c~ange

in the rate of rise.

~et

in _several

experiments facilitatory drugs did increase the rate of rise of ACh-potentials without prolongation.

Although not reported as such, the records of

Katz and Thesleff (1957a) especially figure 1 -..,. give similar results with
edrophonium in frog muscle.

This increase in ACh-potential amplitude

with no prolongation indicates that cholinesterase affects only the quantity
of ACh reaching the e. p.

In other words cholinesterase inhibition, espe- ·

cially low levels of inhibition, produces no prolongation of ACh action.
Diffusion must be the major mechanism of termination of the action of
iontophoretic ACh.

It is difficult to determine if the same mechanism holds

true for the involvement of cholinesterase in the generation of the e. p. p.
It has been hypothesized that diffusion is quite important in the decay of

transmitter action (Ogston, 1955), but it is unknown how important
cholinesterase is in determining the initial quantity of transmitter reaching.
the e. p.

This observation on the effects of facilitatory drugs does not

support the idea that cholinesterase inhibition can not increase the rate of
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rise of (+)-tubocurarine e. p. p..s. This increase in the rate of rise j.s most
prominent at concentrations of facilitatory drug, that do not prolong the
e. p. p.

At higher drug concentrations there is prolongation of the e. p. p ••

indicating that cholinesterase inhibition does lengthen the action of the
neuromuscular transmitter.

The primary effect of facilitatory drugs on (+)-tubocurarine e. p. p. s
in isolated mammalian muscle is cholinesterase inhibition.
sion is supported by studies on quantal content..

This conclu-

None of the drugs tested

produce increases in the quanta! release of the e. p. p. at concentrations
whid1 produce large increases in (+)-tu.bocurarine e. p. p. s.

Thus changes

in amplitude of e. p. p. s in a high magnesium ion concentration parallel
changes in amplitude of m. e. p. p. s.

This result indicates a mechanism

of action for the facilitatory drugs which is postsynaptic, and this .action
may well be cholinesterase inhibition.

Benzoquinonium blocks neuromuscular transmission much like
(+)-tubocurarine, but blockade by benzoquinonium is not antagonized by
facilitatory drugs (Bowman, 1958).

As benzoquinonium e. p. p. s are

prolonged (compared to (+)-tubocurarine e. p. p. s). it is likely that
cholinesterase is at least partially inhibited by benzoquinonium.

In vitro

~·; '
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results indicate that benzoquinonium is nearly as potent as neostigmine
in inhibiting cholinesterase {Blaber and Bowman, 1962).

This inhibitio~

may explain the ability of benzoquinonium to augment the (+)-tubocurarine
e. p. p. amplitude.

Also, previous inhibition of cholinesterase by benzo-

quinonium limits the in..'1ibition of cholinesterase produced by the facilitatory drugs.

The theory of cholinesterase inhibition by facilitatory drugs is support-•
ed by experiments on neuromuscular depression produced by paired stimuli
to isolated curarized frog muscle preparations.

··, ..

Neuromuscular depression

is not affected by edrophonium or physostigmine (Takeuchi, 1958a; Otsuka,
Endo and Nonomura, 1962 and Otsuka and Nonomura, 1963). If the facilitatory drugs increase the release of transmitter. they should increase the
depletion-induced depression resulting from paired stimuli.

Although

this work was performed in frogs it is probably applicable to mammalian
preparations.

Although cholinesterase inhibition appears to be the primary action
of facilitatory drugs on e. p. p. s, this action does not explain the sponta neous twitching observed in the presence of ambenonium.

Originally, it

was thought that m. e. p. p. s are augmented to such an extent by facilitatory
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drugs that they give rise to propagated muscle action potentials.

But Katz

and Thesleff (1957b) concluded that even in small muscle fibers, cholin- ·
,

esterase inhibition could not augment m. e. p. p. s sufficiently to induce
muscle action potentials.

It is possible that spontaneous twitching is due to

spontaneous giant potentials (Liley, 1957). except giant potentials have been
observed only in the rat diaphz:agm.

Furthermore if they can give rise to

fibrillations, they can not cause fasciculations.
induced by motor unit

Fasciculations must be

a~tivity.

A possible origin of drug-induced fasciculations is suggested by the

experiments of Hubbard, Schmidt and Yokota (1965).

Neostigmine ·(3. 3 x

10- 6M) reduces the stimulus threshold of a nerve terminal in the presence
of (+)-tubocurarine or excess magnesium and decreased calciµm.Ringers.
This apparent depolarization may initiate propagated activity in the motor
nerve, which could spread throughout the motor unit giving rise to a
fasciculation and antidromic activity (Masland and Wigton, 1940).
Neostigrnine, edrophonium and ambenonium initiate spontaneous
fasciculations and spontaneous antidromic nerve action potentials in vivo
(Blaber and Goode, 1968).

As neostigmine and edrophonium do not

produce spontaneous twitching in isolated muscle, it is likely that in vitro
preparations are not as responsive to facilitatory drugs as in vivo
preparations.
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Methoxyambenonium is as potent as neostigmine and edrophonium in
augmenting the (+)-·tubocurarine e. p. p., but is unable to facilitate an
indirect, maximal twitch (Blaber, 1960).

If the sole mechanism of action

_ .. ...of facilitatory drugs is cholinesterase inhibition, methoxyambenonium
should al so produce facilitation of the maximal twitch.

Blaber and Goode

(1968) observed that methoxyambenonium is incapable of initiating.
spontaneous antidromic nerve activity.

Initiation of spontaneous activity

may involve the same mechanism of action as facilitation of transmission.
If this is the case, methoxyambenonium would not be expected to facilitate

the muscle twitch.
Repetitive muscle activity after an orthodromic stimulus lasts for

c::.

period of approximately 50 msec in the presence of a facilitatory drug
(Blaber and Bowman, 1963a). The longest (+)-tubocurarine e. p. p. observed
in the presence of high concentrations of a facilitatory drug, has a
half fall of only 2. 8 msec.

This degree of prolongation would not giv·e

rise to prolonged repetitive muscle activity.

It is necessary to assume

that (+)-tubocurarine drastically decreases the prolongation induced by
the facilitatory drugs (Eccles, Katz and Kuffler, 1942 and Karczmar,
Koketsu and Soeda, 1968).

Only in the presence of a deficient sodium ion

concentration do facilitatory drugs pro long e. p. p. s to such an extent
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(Fatt arid Katz, 1951 and Kordas, 1968).

This discrepancy between e. p. p.

half-decay time and length of repetitive activity suggests that a mechanism
other than cholinesterase inhibition is involved in facilitation.

;--The occurrence of spontaneous twitching makes it seem likely that a
pre synaptic mechanism is involved in the action of facilitatory drugs.

The

explanation, as to why it does not occur in the e. p. p. studies, may be
involved in the depressant action of tubocurarine on the motor nerve
terrninal.

Small doses of tubocurarine depress the supernormal period

of the nerve terminal spike (Hubbard and Schmidt, 1961 and Hubbard,
Schmidt and Yokota, 1965) and drug-induced antidromic nerve activity
(Werner, 1961; Blaber and Bowman, 1963b and Standaert, 1964).

As the

concentration of (+)-tubocurarine used in these experiments was well over
the concentration necessary to produce 100% block of the muscle twitch, it
is quite possible that the nerve terminal action of facilitatory drugs was
completely depressed in these experiments.

Defici_ent calciurn ions and benzoquinonium ;:ire even n1ore effective
in blocking the terminal act ions of facilitatory drugs.

For this reason a

terminal effect would not be expected to occur in their presence either
(Hubbard, Schmfdt and Yokota, 1965 and Blaber and Bowman, 1963a:).
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This depressant effect of blocking drugs may be amplified by the abnormal
environment of the isolated muscle.

THEORY OF THE MECHANISM OF DRUG-INDUCED FACILITATION AND
ANTI-Tc ACTION AT THE SKELETAL NEUROMUSCULAR JUNCTION

The mechanisms of drug-induced facilitation and anti-Tc action by
facilitatory drugs are at present in hypothetical stages.

All facilitatory

drugs appear to act at at least three sites:
1)

cholinesterase,

2)

directly at the e. p. , and

3)

presynaptically.

The relative importance of each site of action depends on the particular
drug being considered.

· - - The presynaptic action of neostigmine, ed·rophonium, ambenonium and
rr1ethoxyambenonium has not been clearly elucidated.

It does not involve

depolarization of the motor nerve terminal in the same manner as
potassium ions.

Yet neostigmine, edrophonium and ambenonium do depo-

larize the terminal at another site, possibly the first node, as hypothesized
by Hubbard, Schmidt and Yokota (1965) and Blaber and Goode (1968).

This

..-------------------------------------------------v_..____________.....,______..,.,
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initiates spontaneous twitching.

Methoxyambenonium blocks at this site,

thus it is not capable of inducing spontaneous antidromic activity. · This is
probably a direct action (not mediated by ACh)(Hubbard, 1965) as ACh did
not produce spontaneous twitching.

Also edrophonium and neostigmine

should have produced spontaneous twitching at some concentration if the
effect was due to ACh accumulation.

Neo$tigmine increases the duration of the nerve terminal action
potential and negative after potential (Hubbard and Schmidt, 1961 and
Hubbard, Schmidt and Yokota, 1965).

A longer duration of the terminal

action potential should lead to increased release of transmitter.
prolonged negative afterpotential may also increase release

The

somei..~hat;

although according to Liley's theory (1956c), this release would be
insignificant.

To hypothesize that an augmented negative afterpotential

increases the release of transmitter, it is necessary to hypothesize that an
additional factor is involved (maybe calcium is accumulated,
intraterminally).

The augmented negative afterpotential probably generates antidromic
nerve activity.

This antidromic activity passes into the ventral root where

it is recorded.

Also, when it reaches a nerve terminal branch, it may
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pass orthodromically into another terminal.

This reverberation could

lead to a continuous release of transmitter.

,

.

In addition to a presynaptic action, facilitatory drugs inhibit junctional
cholinesterase. _It is .ctifficJlll.to as_se_ss'Jhe r:o1e_Qf.cb_olineste.rase
inhibition in facilitation.

Yet this appears to be the primary mechanism

involved in antagonism of high concentrations of (+)-tubocurarine.
The direct actions of facilitatory drugs have only a very minor role in
facilitation and antagonism of (+)-tubocurarine but they may be responsible
for blockade of neuromuscular transmission at high concentrations.
These same mechanisms probably are involved in the action of every
drug.at the neu.r.omus cular junction.

The importance of each action is

determined by the chemical structure of the drug being studied.
Depolarizing drugs act primarily by a direct, depolarizing action, but they
also act at the nerve terminal and inhibit cholinesterase.

Competitive

blockers have a potent competitive blocking action, but may act at the
terminal and inhibit cholinesterase (e.g. benzoquinonium).

TEA and

guanidine act primarily at the nerve terminal, but also exhibit direct
actions.

Thus the effect of a drug depends not on any one site of action

but upon the sum of actions at many sites.

·•.
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SUMMARY

1)

The facilitatory drugs (neostigmine, edrophonium, ambenonium and

methoxyambenonium) produced only small changes in m. e. p. p.
frequency.

As this effect was small compared to the effect of potassium

ions, it was concluded that the facilitatory drugs did not significantly
change the nerve terminal membrane potential.
2)

In all experiments in which no blocking drugs were present ambenonium

produced
3)

spontaneous twitching.

Each of the facilitatory drugs augmented but did not prolong the Tc

e. p. p.

Furthermore this augmentation of c. p. p. amplitude occurred ai

low concentrations of facilitatory drug which had no effect on m. e. p. p.
amplitude or time-course.

This lack of correlation implicated a

presynaptic site of drug action.
4)

When A Ch-potentials and Tc e. p. p. s were recorded, simultaneously;

both were augmented by the same minimal concentration of facilitatory
drug.

However, the concentration of drug necessary to augment the Tc

e. p. p. was higher when A Ch was applied to the e. p. by iontophoresis
than in the experiments summarized in 3) above.
5)

The facilitatory drugs did not augment the carbachol-potential at any

concentration.
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6)

The facilitatory drugs did not increase the quantal content of -the

e. p. p. recorded in the presence of a low ·calcium ion and high magnesium
ion concentrations.
7)

Benzoquinonium administration, unlike Tc, caused a continuous

decline in e. p. p. amplitude.

The benzoquinonium e. p. p. had a longer

half-decay time, which is indicative of its ability to inhibit junctional
cholinesterase.

The facilitatory drugs were ineffective in augmenting

the benzoquinonium e. p. p.
8)

The correlation between the :minimal concentrations necessary to

augment the Tc e. p.p. and ACh-potential indicates that most of the
effects of the facilitatory drugs in antagonizing Tc are due to a
postsynaptic action.

This postsynaptic action is probably cholinesterase

inhibition, as the facilitatory drugs had no effect on the carbachol
potential.

The lack of correlation between effects on m. e. p. p. s and Tc

e. p. p. s indicates that these drugs might have a weak presynaptic action
in the antagonism of Tc.
9)

The conclusion that the primary effect of the facilitatory drugs is

due to cholinesterase inhibition is supported by the lack 0f effect of
these drugs on quantal release.

Also most of the actions of benzo-

quinonium can be explained by it cholinesterase inhibiting properties.
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10)

Cholinesterase inhibition can not account for the production o.f

spontaneous twitching by ambenonium.

Thus a presynaptic effect must

occur in the absence of Tc.
li)
the

On the basis of these results it seems that a presynaptic action of
fa~ilitatory

drugs is minimal in the presence of high concentrations

of Tc which are necessary for use of microelectrode recording
techniques.

,,.
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